Atherosclerosis, Supplements

Nitric oxide release by nitrated linoleic acid products - E.S. Lima¹, P. DiMascio², F. Laurindo³, H. Rubbo⁴, D.S.P. Abdalla¹. ¹School of Pharmaceutical Sciences, ²Institute of Chemistry, University of Sao Paulo; ³Heart Institute (InCor), Sao Paulo, Brazil; ⁴School of Medicine, University of Republic, Montevideo, Uruguay
pp. 65-65(1)

Effect of simvastatin and its association with L-arginine and alpha-tocopherol on asymmetrical dimethylarginine and nitric oxide metabolites - E.C. Pereira¹, M.C. Bertolami², A.A. Faludi², D.S.P. Abdalla¹. ¹School of Pharmaceutical Sciences, University of Sao Paulo; ²Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil
pp. 65-65(1)

Effect of isoflavones on homocysteine and nitric oxide derivatives in hypercholesterolemic and hypertensive postmenopausal woman - I.R.O. Pereira¹, M.C. Bertolami², A.A. Faludi², J.M. Aldrighi³, D.S.P. Abdalla¹. ¹School of Pharmaceutical Sciences, University of Sao Paulo; ²Institute Dante Pazzanese of Cardiology, Sao Paulo; ³School of Public Health, University of Sao Paulo, Brazil
pp. 65-65(1)

Influence of atorvastatin on the expression of hepatic triglyceride lipase - D. Ahl, J. Thumfart, W. Marz, M.M. Hoffmann. University Hospital Freiburg, Germany
pp. 65-65(1)

Secretory products of adipocytes: The good players versus the bad - G. Ailhaud. Centre de Biochimie, UMR6543CNRS, Faculte des Sciences, Parc Valrose, Nice, France
pp. 65-65(1)

LDL and HDL subclass distribution in patients with end-stage renal diseases - S.B. Alabakovska, B.B. Todorova, D.D. Labudovic, K.N. Tosheska. Department of Medical Biochemistry, Skopje, Macedonia
pp. 66-66(1)

Statin treatment assessed by magnetic resonance - J.P. Albertini¹, H. Laouenan², P. Valensi², L. Le Moyec². ¹SMBH, Hopital Avicenne, Bobigny; ²Pfizer, Paris, France
pp. 66-66(1)

Plasma urokinase as predictor of recurrent angina after coronary angioplasty - I. Alekseeva, Y. Parfyonova, A. Lyakishev, A. Dobrovolsky, Z. Gabbasov, V. Naumov. Cardiology Research Centre, Moscow, Russia
pp. 66-66(1)

Association between serum homocysteine and coronary heart disease in a finnish high-risk male population - G. Alfthan¹, P. Jousilahti¹, J.T. Salonen², J. Tuomilehto¹. ¹National Public Health Institute, Helsinki; ²Research Institute of Public Health, University of Kuopio, Finland
pp. 66-66(1)

Membrane protective effect of prestarium in hypertensives with heart failure - I.G. Alizade, N.T. Karaeva. Hospital of Ministry of Internal Affairs, Baku, Azerbaijan
pp. 66-66(1)

The acute effects of insulin on chylomicron metabolism in viscerally obese and lean men - E.M. Allister¹, A.P. James¹, J.C.L. Mamo¹, P.H.R. Barrett², M. Soares¹, G.F. Watts². ¹Curtin University; ²University of Western Australia, Perth, WA, Australia
pp. 66-67(2)

The acute effects of insulin on chylomicron metabolism in vitro - E.M. Allister, S. Pal, J.C.L. Mamo. Curtin University, Perth, WA, Australia
pp. 67-67(1)

A complex splicing defect of ABCA-1 pre-mRNA caused by a G -> C transversion at position +5 of intron 2 of ABCA-1 gene - S. Altilia¹, R. Garuti¹, L. Pisciotta², S. Bertolini², C. Vergani³, S. Calandra¹. ¹University of Modena and Reggio Emilia, Modena; ²University of Genova; ³University of Milano, Italy
pp. 67-67(1)

A LDLR genomic screening strategy reveals novel and splicing regulatory mutations causing familial hypercholesterolemia - S. Amsellem¹, D. Briffaut¹, A. Carrie², J.P. Rabes³, J.P. Girardet⁴, A. Fredenrich⁵, P. Moulin⁶, M. Krempf⁷, Y. Reznik⁸, B. Vialettes⁹, J.L. De Gennes¹⁰, E. Bruckert¹⁰, P. Benlian¹. ¹Department of Biochemistry and Molecular Biology, Hopital Saint Antoine, Paris; ²Department of Biochemistry, Pite Salpetriere Hospital, Paris; ³Department of Biochemistry, Ambroise Pare Hospital, Boulogne Billancourt; ⁴Department of Pediatrics, Trousseau Hospital, Paris; ⁵Department of Metabolic Diseases, Pasteur Hospital, Nice; ⁶Department of Metabolic Diseases, Antiquaille Hospital, Lyon; ⁷Depa
pp. 67-67(1)

Single allele double mutants in heterozygous familial hypercholesterolemia - S. Amsellem¹, D. Briffaut¹, O. Khallouf¹, J.P. Rabes², J.P. Girardet³, A. Fredenrich⁴, P. Moulin⁵, Y. Reznik⁶, B. Vialettes⁷, J.L. De Gennes⁸, E. Bruckert⁹. ¹Department of Biochemistry and Molecular Biology, Hopital Saint Antoine, Paris; ²Department of Biochemistry, Ambroise Pare Hospital, Boulogne Billancourt; ³Department of Pediatrics, Trousseau Hospital, Paris; ⁴Department of Metabolic Diseases, Pasteur Hospital, Nice; ⁵Department of Metabolic Diseases, Antiquaille Hospital, Lyon; ⁶Department of Metabolic Diseases, Cote de Nacre Hospital, Caen; ⁷Department of Metabolic Diseases, Sainte Marguerite Hospital, Marseille; ⁸Department of Metabolic Diseases, Pitie Salpetrie
pp. 67-68(2)

Six lipoprotein lipase SNPs, levels of triglyceride and HDL, and risk of ischemic heart disease (IHD); The Copenhagen City Heart Study - H.H. Wittrup¹, R.V. Andersen¹, G. Jensen², R. Steffensen³, A. Tybjaerg-Hansen^2,4, B.G. Nordestgaard^1,2. ¹Department of Clinical Biochemistry, Herlev University Hospital, Copenhagen; ²The Copenhagen City Heart Study, Bispebjerg University Hospital, Copenhagen; ³Department of Medicine B, Hilleroed Hospital, Hilleroed; ⁴Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
pp. 68-68(1)

Relationship between total antioxidant status and blood lipids in healthy women - M. Andonovska. Medical Center, Kumanovo, Republic of Macedonia
pp. 68-68(1)

Does immunomodulation of coronary atherosclerosis have the future? - E. Andreeva. St. Petersburg State Medical Academy, St. Petersburg, Russia
pp. 68-68(1)

Local lipid deposition in uninvolved human aortic intima correlates with inflammatory cells' accumulation and inflammatory activation of vessel wall cells - E.R. Andreeva¹, I.A. Mikhailova¹, A.N. Orekhov². ¹Institute of Experimental Cardiology, Cardiocenter, ²Institute for Atherosclerosis Research, Russian Academy of Natural Science, Moscow, Russia
pp. 68-68(1)

Apolipoprotein E polymorphism and carotid atherosclerosis in patients with coronary disease - C. Fernandez-Miranda, J.L. Aranda, M.A. Martin, J. Arenas, V. Nunez, A. Gomez De La Camara. Hospital Universitario 12 De Octubre, Madrid, Spain
pp. 68-69(2)

Antioxidant effect of the essential oils of Iranian conifers and vitamin C on LDL oxidation - S. Asgary, G.H. Naderi, A. Emami, M.R. Shams Ardekani, T. Kesher, M. Gharipour. Isfahan Cardiovascular Research Center, Isfahan, Iran
pp. 69-69(1)

Anti-atherogenic effects of anti-inflammatory drug in the hypercholesterolemic rabbit - S. Asgary, G.H. Naderi, F. Kafil, A. Sajjadian, S.H. Azali. Isfahan Cardiovascular Research Center, Isfahan, Iran
pp. 69-69(1)

Is there any differences between the lipid peroxidation and anti-oxidant capacity between addict and non-addict? - S. Asgary, G.H.A. Naderi, J. Sharezaei, P. Ahmadi. Isfahan Cardiovascular Research Center, Isfahan, Iran
pp. 69-69(1)

The antioxidant activity of the essential oils of Iranian conifers on red blood cell - S. Asgary, M.R. Shams Ardekani, G.H. Naderi, A. Emami, S. Aslani, S.H. Azali. Isfahan Cardiovascular Research Center, Isfahan, Iran
pp. 69-69(1)

Ruptured plaques, ulcers and thickened intima: That's how man looks inside - I. Asmussen. Cardiology Section, Medical Department, County Hospital Sogn and Fjordane SSSF, Foerde, Norway
pp. 69-70(2)

Treatment with atorvastatin to the national cholesterol educational program goals versus usual care in secondary coronary heart disease prevention. The greek atorvastatin on coronary-heart-disease evaluation (greace) study - A.G. Athyros¹, A.A. Papageorgiou¹, B.R. Mercouris², V.V. Athyrou¹, A.N. Symeonidis², E. Basayannis¹, D.S. Dimitriadis¹, A.G. Kontopoulos¹. ¹Atherosclerosis Unit, Aristotelian University, Hippocration Hospital; ²Greek Society of General Practitioners, Thessaloniki, Greece
pp. 70-70(1)

Long-term treatment effect of atorvastatin on aortic elasticity in hypercholesterolemic patients - V.G. Athyros¹, A.G. Kontopoulos¹, A.N. Pehlivanidis¹, D.S. Dimitriadis¹, A.A. Papageorgiou¹, H. Boudoulas². ¹Atherosclerosis Unit, Hippocration Hospital, Aristotelian University, Thessaloniki, Greece; ²Division of Cardiology, Ohio State University, Columbus, OH, USA
pp. 70-70(1)

Atorvastatin and micronized fenofibrate, alone and in combination, in type-2 diabetes mellitus with combined hyperlipidemia - V.G. Athyros, A.A. Papageorgiou, V.V. Athyrou, D.S. Dimitriadis, A.G. Kontopoulos. Atherosclerosis Unit, Hippocration Hospital, Aristotelian University, Thessaloniki, Greece
pp. 70-70(1)

Effect of Taq IB CETP gene polymorphism on cholesteryl ester transfer activity and lipid parameters in a Tunisian type 2 diabetic population - N. Attia¹, O. Mandhouj², K. Ben Hamda³, A.-S. Masmoudi¹, R. Chaaba¹, M. Smaoui¹, S. Hammami³, P. Moulin⁴, A. Girard-Globa⁴, M. Hammami¹. ¹Biochemistry Laboratory, ²Community Medicine Department, Faculty of Medicine; ³Fattouma Bourguiba Hospital, Monastir, Tunisia; ⁴Laboratory of Lipid Metabolism, Antiquaille Hospital, Lyon, France
pp. 70-71(2)

The relationship between carotid artery disease severity and stroke prevalence in patients undergoing coronary artery bypass surgery - S. Aytekin¹, Z. Ozyedek¹, V. Aytekin¹, E. Kabatas¹, E. Rizaoglu¹, B. Akpinar², O. Yildirimturk¹, R. Ozcan¹, I.C.C. Demiroglu¹, C.E.M.I. Demiroglu¹. ¹Cardiology Department, ²Cardiovascular Surgery, Kadir Has University, Istanbul, Turkey
pp. 71-71(1)

Risk factors and peripheric artery disease prevalance in coronary artery disease patients who also have carotid artery disease - S. Aytekin¹, Z. Ozyedek¹, V. Aytekin¹, E. Kabatas¹, E. Rizaoglu¹, B. Akpinar², O. Yildirimturk¹, R. Ozcan¹, I.C.C. Demiroglu¹, C.-I. Demiroglu. ¹Cardiology Department, ²Cardiovascular Surgery Department, Kadir Has University, Istanbul, Turkey
pp. 71-71(1)

Pravastatin up-regulates TGF-1 in THP-1 human macrophages: Effect on scavenger receptor class a expression - G. Baccante, G. Mincione, M.C. Di Marcantonio, A. Piccirelli, E. Porreca. D'Annunzio University, Chieti, CH, Italy
pp. 71-71(1)

Lipoproteins and endothelial cell function. Regulation of gene expression - L. Badimon, B. Raposo, C. Rodriguez. Instituto Investigacion Cardiovascular de Barcelona, CSIC-ICCC, Barcelona, Spain
pp. 71-72(2)

Kinetic study of HDL selective cholesteryl ester uptake in dogs using stable isotopes - E. Bailhache^1,2, K. Ouguerram¹, P. Nguyen²; P. Maugere¹, M. Krempf¹, T. Magot¹. ¹INSERM U539, Groupe Metabolisme; ²Ecole Nationale Veterinaire, Nantes, France
pp. 72-72(1)

The scavenger receptor class B, type I colocalizes with caveolae and promotes partitioning of HDL associated alpha-tocopherol into caveolae in porcine brain capillary endothelial cells - Z. Balazs, U. Panzenbock, A. Sovic, W. Sattler. Karl-Franzens-University, Institute of Medical Biochemistry and Medical Molecular Biology, Graz, Austria
pp. 72-72(1)

Efficacy and safety of simvastatin versus atorvastatin: Results of the comparative HDL-C efficacy and safety study (Chess) - C.M. Ballantyne¹, C.M. Hustad², Z. Yuan², P. DeLucca², J. Palmisano². ¹Baylor College of Medicine, Houston, TX; ²Merck & Co., Inc., West Point, PA, USA
pp. 72-72(1)

Effect of atorvastatin on the kinetics of apolipoprotein AIV in non insulin dependent diabetics - F. Ferrer¹, H. Nazih^1,2, K. Ouguerram^1,3, M. Krempf¹, H. Laouenan⁴, J.-M. Bard^1,2. ¹INSERM U539 et CHU; ²UFR de Pharmacie; ³UFR de Sciences, Nantes; ⁴Laboratoires Pfizer, Paris, France
pp. 72-72(1)

The 5A/6A stromelysin polymorphism and echogenic plaques: Dewsbury and maidstone part of the british regional heart study - E. Bashiardes¹, M. Cariolou¹, M. Giffin², A. Nicolaidis¹, A. Karagrigoriou³, S. Ebrahim⁴, S.E. Humphries⁵. ¹The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus; ²Imperial College, London, UK; ³University of Cyprus, Nicosia, Cyprus; ⁴Bristol University; ⁵Royal Free and University College London, UK
pp. 72-73(2)

Is lifetime tobacco smoking associated with atherosclerosis and arterial stiffness in 36-year old men and women? The amsterdam growth and health longitudinal study - E.H.C.M. Bekkering¹, C.M. Bernaards¹, J.W.R. Twisk¹, C.D.A. Stehouwer, W. Van Mechelen, H.C.G. Kemper. ¹Institute for Research in Extramural Medicine, Department of Internal Medicine, ²Department of Social Medicine, VU University Medical Center, Amsterdam, The Netherlands
pp. 73-73(1)

Homocysteinemia and coronarian risk - C. Belizna¹, M.A. Pistorius², B. Planchon². ¹CHU Fundeni, Bucharest, Romania; ²CHU Hotel Dieu, Nantes, France
pp. 73-73(1)

LIMB Ischaemia and leukaemia - C. Belizna¹, M.A. Pistorius², B. Planchon². ¹CHU Fundeni, Bucharest, Romania; ²CHU Hotel Dieu, Nantes, France
pp. 73-73(1)

The LDL receptor gene in FH: Is the founder of the family ready to step into the ERA of clinical practice? - P. Benlian. Hopital Saint Antoine, Paris, France
pp. 73-73(1)

Interleukin-6 levels and genotypes in relation to myocardial infarction; results from the sheep study - A.M. Bennet¹, J. Prince², L. Lyrenes³, B. Wiman⁴, J. Frostegard^5,6, U. de Faire^1,7. ¹Division of Cardiovascular Epidemiology, Institute of Environmental Medicine; ²Division of Clinical Genomics, Center for Genomics and Bioinformatics; ³Division of Biochemical Toxicology, Institute of Environmental Medicine; ⁴Division of Coagulation Research, ⁵Division of Rheumatology, ⁶Centre for Molecular Medicine, ⁷Department of Cardiology, Karonlinska Hospital, Stockholm, Sweden
pp. 73-74(2)

Pleiotropic antiatherosclerotic effect of lipophilic calcium antagonists in macrophages - F. Bernini¹, N. Baldini¹, I. Zanotti¹, M. Canavesi², E. Favari¹, S. Bellosta². ¹University of Parma; ²University of Milan, Italy
pp. 74-74(1)

Statins: Old drugs and new developments - the role of statins in diabetic dyslipidaemia - D.J. Betteridge. University College London, UK
pp. 74-74(1)

Role of various adhesion and activation molecules in patients with coronary artery disease - G. Dwivedi¹, R. Vijayvergiya¹, A. Grover¹, Y.P. Sharma¹, A. Bhatnagar², S. Majumdar². ¹Department of Cardiology, ²Department of Experimental Medicine, PGIMER, Chandigarh, India
pp. 74-74(1)

Role of nitric oxide in patients with established coronary artery disease - G. Dwivedi¹, R. Vijayvergiya¹, A. Grover¹, Y.P. Sharma¹, A. Bhatnagar², S. Majumdar². ¹Department of Cardiology, ²Department of Experimental Medicine, PGIMER, Chnandigarh, India
pp. 74-74(1)

Upregulation of immune system in familial hypoalphalipoproteinemia - F. Bigazzi, B. Dal Pino, E. Chella, M. Puntoni, L. Ciulli, S. Lusso, G. Sassi, M. Tuoni, T. Sampiertro, A. Bionda. Institute of Clinical Physiology CNR, Department of Internal Medicine, University of Pisa, Italy
pp. 75-75(1)

Ischemia- and TNF--induced priming of blood macrophages increases their ability to oxidatively modify circulating LDL in aerobic and ischemic conditions
pp. 75-75(1)

Inflammatory activation of vascular cells: Cellular and molecular mechanisms - B.R. Binde. Department of Vascular Biology and Thrombosis Research, Vienna, Austria
pp. 75-75(1)

Efficacy of a new protocol of selective apheresis in inducing atherosclerosis regression in a child with homozygous familial hypercholesterolemia - T. Sampietro¹, M. Tuoni², B. Dal Pino¹, F. Bigazzi², M. Taddei², A. Ciardi², E. Chella², S. Lusso², A. Vallini², M.R. Puntoni¹, A. Bionda². ¹CNR Institute of Clinical Physiology, ²Department of Intenal Medicine, University of Pisa, Italy
pp. 75-75(1)

Cholesterol absorption and biosynthesis after hypolipidemic intervention by LDL-apheresis - V. Blaha¹, R. Hyspler¹, M. Blaha², D. Solichova¹, P. Zdansky¹, E. Havel³, P. Vyroubal¹, Z. Zadak¹, J. Maly². ¹Department of Metabolic Care and Gerontology, ²Department of Clinical Hematology, ³Department of Surgery, Faculty Hospital Charles University, Hradec Kralove, Czech Republic
pp. 75-76(2)

Assessment of antioxidative barrier enzymes activity during fluvastatin and atorvastatin therapy used in coronary heart disease primary prophylaxis - J. Blaszczyk, J. Kowalski, L. Pawlicki, J. Greycewicz, E. Rapacka, P. Kaczmarek. Military Medical University, Lodz, Poland
pp. 76-76(1)

Effect of cholate on cholesterol concentration and hepatic tissue in apolipoprotein e deficient mice - D. Bobkova, R. Poledne. Institute of Clinical and Experimental Medicine, Prague, Czech Republic
pp. 76-76(1)

Oxidized phospholipids inhibit action of endotoxin in vitro and in vivo - V. Bochkov, A. Kadl, J. Huber, F. Gruber, B.R. Binder, N. Leitinger. Institute of Vascular Biology and Thrombosis Research, University of Vienna, Austria
pp. 76-76(1)

Serum kinetics of the biochemical markers for acute myocardial infarction - M.M. Bogdanova, S.R. Domazetovsks, V.P. Arsova. Institute of Clinical Biochemistry, Clinical Center Skopje, Macedonia
pp. 76-76(1)

Cardiovascular prevention in the general practice (1): Detection of barriers - R. De Muylder, V. Lorant, C. Prevost, F. Nackers, M. Jeanjean, B. Boland. School of Public Health, Louvain University, Brussels, Belgium
pp. 76-77(2)

Cardiovascular prevention in the general practice (2): A clinical algorithm - B. Boland¹, R. De Muylder¹, D. Paulus¹, Y. Gueuning², P. Legat², M. Jeanjean¹. ¹School of Public Health, Louvain University, Brussels; ²Belgian Scientific Society of General Practice, Belgium
pp. 77-77(1)

Cardiovascular prevention in the general practice (3): Impact of a specific training - R. De Muylder, F. Nackers, D. Pestiaux, R. Tonglet, M. Jeanjean, B. Boland. Louvain University, Brussels, Belgium
pp. 77-77(1)

Selective screening of genetic dislipemias in italian children - C. Bondone¹, G. Mercadante², C. Allora¹, I. Rabbone¹, O. Guardamagna¹. ¹Department of Paediatrics, ²Department of Geriatrics, University of Turin, Italy
pp. 77-77(1)

Blood lipoproteins, antioxidant enzymes and homocysteine in healthy middle-aged women according the menopausal status - G.L. Bosilkova, S.A. Dzhekova-Stojkova, M.A. Krstevska. Department of Medical Biochemistry, Medical Faculty, Skopje, Macedonia
pp. 77-77(1)

Systemic inflammation, chlamydia pneumoniae DNA in circulating leukocytes and coronary atherosclerosis - J.M. Bosmans¹, V. Hoymans¹, D. Ursi¹, F. Dubois¹, E. Van Marck¹, M. Altwegg², M. Ieven¹, C. Vrints¹. ¹University of Antwerp, Edegem, Belgium; ²University of Zurich, Switzerland
pp. 78-78(1)

Augmented monocytic proinflammatory cytokines in acute coronary syndromes: Relation with plaque inflammation and rupture, and with neointimal thickening - J.M. Bosmans, A.J. Schuerwegh, L.S. De Clerck, F.L. Wuyts, M.M. Kockx, W.J. Stevens, C.J. Vrints. University of Antwerp, Edgem, Belgium
pp. 78-78(1)

Plasma lipid levels in patients with venous thrombosis - S. Bottazzo, G. Pagan, P. Atanasio, A. Nogara, P. Zanchi. Umberto I Hospital, Venezia-Mestre, Italy
pp. 78-78(1)

Identification of molecular defects in portuguese patients with familial hypercholesterolaemia - M. Bourbon^1,7, Q. Rato², J.M. Silva³, A. Guerra⁴, P.M. Silva⁵, H.G. Santos⁶, J. Lavinha¹, A.K. Soutar⁷. ¹Instituto Nacional Saude Dr. Ricardo Jorge, C. Biopatologia, Lisbon; ²Hospital S. Bernardo S. Cardiologia, Setubal; ³Hospital Universidade Coimbra, S. Medicina II, Coimbra; ⁴Hospital S. Joao, S. Pediatria, Oporto; ⁵Hospital Sta. Marta, S. Medicina, Lisbon; ⁶Hospital Sta. Maria, S. Genetica, Lisbon, Portugal; ⁷Medical Research Council, Lipoprotein Group, London, UK
pp. 78-78(1)

Mean platelet volume and the number of large platelets in atherosclerotic patients - L.I. Bouriatchkovskaia, I.A. Uchitel, E.M. Rogova, A.B. Sumarokov, G. Chernina, V.G. Naumov. Cardiology Research Complex, Moscow, Russia
pp. 78-79(2)

Long term efficacy of low fat low cholesterol diet in the management of hypercholesterolemia - A. Branchi¹, A.M. Fiorenza², F. Muzio², A. Torri², C. Berra², E. Colombo², E. Dalla Valle², D. Sommariva². ¹Department of Internal Medicine, University of Milan, Maggiore Hospital IRCCS, Milan; ²Department of Internal Medicine, G. Salvini Hospital, Garbagnate Milanese, Italy
pp. 79-79(1)

Effects of simvastatin 40 mg on blood pressure in hypercholesterolemic patients - A. Branchi¹, A.M. Fiorenza², A. Torri², C. Berra², E. Colombo², A. Rovellini¹, D. Sommariva². ¹Department of Internal Medicine, University of Milan, Maggiore Hospital IRCCS, Milan; ²Department of Internal Medicine, G. Salvini Hospital, Garbagnate Milanese, Italy
pp. 79-79(1)

Cardiovascular risk in nonalcoholic fatty liver disease - A. Brea, D. Mosquera, E. Martin, A. Arizti, M.J. Palomo. Lipids Unit, C.H. San Millan-San Pedro, Logrono, La Rioja, Spain
pp. 79-79(1)

Insulin resistance in nonalcoholic fatty liver disease - A. Brea, D. Mosquera, E. Martin, A. Arizti, M.J. Palomo. Lipids Unit, C.H. San Millan-San Pedro, Logrono, La Rioja, Spain
pp. 79-79(1)

Low HDL-cholesterol but not high triglycerides levels are related to intima-media thickening in recently diagnosed type 2 diabetes - E. Brocco, G.L. Guarnieri, A. Breda, M. Scarpel, C. Bravin, A. Gasparoni, F. Giacon, E. Feltrin, A. Maccioni. Internal Medicine Department, P.O. Conegliano, ULSS 7, Veneto, Italy
pp. 79-80(2)

The effect of caffeine on the peripheral vascular resistance in regard of the vasodilatative mechanism of adenosine - M. Brodmann^1,2, U. Lischnigg², A. Lueger², E. Pilger¹, G. Stark^1,2. ¹Division of Angiology, Department of Internal Medicine, ²Division of Pharmacotherapy, Department of Internal Medicine, University Hospital Graz, Austria
pp. 80-80(1)

The evaluation of the no-independent vasodilatative effect of iloprost in isolated perfused guinea pig hind limbs - M. Brodmann^1,2, U. Lischnigg², A. Lueger², E. Pilger¹, G. Stark^1,2. ¹Division of Angiology, Department of Internal Medicine, ²Division of Pharmacotherapy, Department of Internal Medicine, University Hospital Graz, Austria
pp. 80-80(1)

Genetic evaluation of the common variant of the endothelial nitric oxide synthase (Glu298Asp) in patients with thrombangitis obliterans - M. Brodmann, W. Renner, G. Seinost, E. Pabst, G. Stark, E. Pilger. Division of Angiology, Department of Internal Medicine, University Hospital Graz, Austria
pp. 80-80(1)

Classical risk factors for ischemic heart disease and C-reactive protein in acute coronary syndromes
pp. 80-80(1)

Homozygous familial hypercholesterolemia: Novel therapy with ezetimibe - E. Bruckert¹, C. Gagne², D. Gaudet³, P. Sager⁴, D. Ponsonnet⁴, L. Lipka⁴, A. LeBeaut⁴, R. Suresh⁴, P. Abreu⁴, E. Veltri⁴. ¹Hopital de la Pitie Salpetriere, Paris, France; ²CHUL du Chuq, Quebec; ³Community Genomic Medicine Center, Quebec, Canada; ⁴Schering-Plough Research Institute, Kenilworth, NJ, USA
pp. 81-81(1)

Molecular genetic analysis for familial predisposition to hypercholesterolemia - K.B. Brusgaard, L.S. Krogh H. Haar, P. Jordan, A.G. Shou, K. Rasmussen, A.B. Hansen, M. Hoeder. Department of Clinical Biochemistry and Genetics, Odense Univeristy Hospital, Denmark
pp. 81-81(1)

The influence of analised hypertensive drugs on pulse pressure in patients with mild-to-moderate essential hypertension - W. Bryl, A. Miczke, P. Bogdanski, M. Luczak, M. Cymerys, D. Pupek-Musialik. University of Medical Sciences, Poznan, Poland
pp. 81-81(1)

The influence of analised hypertensive drugs on pulse pressure in patients with mild-to-moderate essential hypertension - A. Miczke, M. Cymerys, W. Bryl, M. Luczak, D. Pupek-Musialik. University of Medical Sciences, Poznan, Poland
pp. 81-81(1)

Does inflammation play important role in pathogenesis of atherosclerosis and its clinical outcome? - I. Burazor, M. Burazor, S. Nagorni, J. Glasnovic, V. Djordjevic, V. Cosic, Z. Burazor, N. Burazor. Clinic for Cardiovascular Diseases, Nis, Yugoslavia
pp. 81-82(2)

Novel truncating APOB gene mutations (APOB-6.9 and APOB-25.8) causing familial hypobetalipoproteinaemia - A.J. Hooper¹, C.E. Herbison², P.H.R. Barrett¹, F.M. Van Bockxmeer^1,2, J.R. Burnett^1,2. ¹University of Western Australia; ²Royal Perth Hospital, Perth, WA, Australia
pp. 82-82(1)

The synergic effect of atorvastatin and quinapril in atherosclerotic rabbits - N. De Las Heras¹, M.P. Oubina¹, S. Vazquez-Perez¹, E. Cediel¹, D. Sanz-Rosa¹, C. Diez², G. Hernandez², V. Lahera¹, V. Cachofeiro¹. ¹Physiology Department, School of Medicine, UCM; ²Medical Division, Pfizer, Madrid, Spain
pp. 82-82(1)

Valsartan improves fibrinolytic balance in atherosclerotic rabbits - M.P. Oubina, N. De Las Heras, S. Vazquez-Perez, E. Cediel, D. Sanz-Rosa, V.Cachofeiro, V. Lahera. Departamento de Fisiologia, Facultad de Medicina, UCM, Madrid, Spain
pp. 82-82(1)

Effects of rosuvastatin alone and combined with extended-release niacin on Apo B- and Apo A-containing lipoproteins and triglycerides in atherogenic dyslipidemia - D.M. Capuzzi, J.M. Morgan, R. Weiss, R.R. Chitra, M.D. Cressman, H.G. Hutchinson. Thomas Jefferson University, Philadelphia, PA; Androscoggin Cardiology Associates, Auburn, ME; AstraZeneca, Wilmington, DE, USA
pp. 82-82(1)

Safety and efficacy of fenofibrate for the treatment of dyslipidemia in AIDS - B. Caramelli¹, C.Y.S.M. De Bernoche¹, A.M.C. Sartori², T.M.V. Strabelli¹, M. Monachini¹, R. Santos¹, D. Uip¹. ¹Heart Institute, ²AIDS Clinic, University of Sao Paulo Medical School, Brazil
pp. 82-83(2)

Short-term treatment with atorvastatin for prevention of cardiac complications after vascular surgery - B. Caramelli, A. Durazzo, D. Ikeoka, C. De Bernoche, M. Monachini, P. Puech-Leao, J.A.F. Ramires. Heart Institute, University of Sao Paulo Medical School, Brazil
pp. 83-83(1)

Insulin resistance and CHD in familial combined hyperlipidemia (FCH) - R. Carmena, J.F. Ascaso, J.T. Real. Hospital Clinico Universitario, Valencia, Spain
pp. 83-83(1)

Granulocyte integrin pattern in diabetes mellitus with macrovascular complications - G. Caimi, C. Carollo, M. Montana, B. Canino, A. Catania, R. Lo Presti. University of Palermo, Italy
pp. 83-83(1)

Identification of asymptomatic patients at increased risk of acute coronary events - M.F. Carrageta. Cardiology Department, Garcia De Orta Hospital, Almada, University Medical School, Lisbon, Portugal
pp. 83-83(1)

Effect of estrogens and phytosoya administration on vascular reactivity in hypercholesterolemic rabbits - C. Castillo, V. Salazar, A. Holguin, S. Gonzalez, V. Cachofeiro, C. Ariznavarreta, J.A.F. Tresguerres. Department of Physiology, Faculty of Medicine UCM, Madrid, Spain
pp. 84-84(1)

High prevalence of R3500Q causing FDB in the Northwest of Spain - S. Castillo¹, D. Tejedor¹, P. Mozas¹, G. Reyes¹, M. Pueyo¹, R. Alonso², P. Mata², J.J. De La Cruz³, M. Pocovi¹, Spanish Group of Fh⁴. ¹Department of Biochemistry and Molecular Biology, University of Zaragoza; ²Unit of Lipids, Fundation Jimenez Diaz, Madrid; ³Department of Preventive Medicine and Public Health, UAM, Madrid, Spain
pp. 84-84(1)

The role of balloon inflation pressure on systemic inflammatory response after percutaneous coronary intervention - V. Aytekin¹, A.B. Catakoglu¹, S. Aytekin¹, I.C.C. Demiroglu¹, H.K. Askin², S. Tufekcioglu², C. Demiroglu¹. ¹Kadir Has University Florence Nightingale Hospital Cardiology Department; ²Florence Nightingale Hospital, Interventional Cardiology, Istanbul, Turkey
pp. 84-84(1)

Endothelium and oxidised lipoproteins - A.L. Catapano^1,2, A. Pirillo¹, F. Pellegatta¹, G.D. Norata¹. ¹Department of Pharmacological Sciences, ²Center for The Study of Atherosclerosis, University of Milan, Italy
pp. 84-84(1)

HMG-CoA reductase inhibitors reduce intima-media thickness and soluble adhesion molecules plasma levels in hypercholesterolemic patients - S. Fantappie², L. Grigore², F.M. Maggi^1,2, K. Garlaschelli², S. Raselli², L. Redaelli², A.L. Catapano^1,2. ¹Department of Pharmacological Sciences, ²Atherosclerosis Center, Bassini Hospital, University of Milan, Italy
pp. 84-85(2)

Endothelial dysfunction and postprandial lipoproteins - F.M. Maggi^1,2, S. Raselli², L. Grigore², L. Redaelli², S. Fantappie², A.L. Catapano^1,2. ¹Department of Pharmacological Sciences, ²Atherosclerosis Center, Bassini Hospital, University of Milan, Italy
pp. 85-85(1)

Achievement of LDL cholesterol goal with addition of plant stanol esters to diets of coronary heart disease (CHD) patients on statin therapy - N.B. Cater, G.L. Vega, S.M. Grundy. Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, TX, USA
pp. 85-85(1)

Evaluation of dose responsiveness to plant stanol esters - N.B. Cater, G.L. Vega, S.M. Grundy. Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, TX, USA
pp. 85-85(1)

Tumor necrosis factor-alpha receptor (sTNF-R) in familial combined hyperlipidemia (FCHL) - G. Cavallo¹, A. Montali¹, L. Monetini¹, L. Valente¹, P. Mariani², R. Cantini¹, T.M. Antonini¹, A. Musca¹, R. Verna³, M. Arca¹. ¹Department of Medical Therapy, ²Department of General Surgery 'P. Stefanini', ³Department of Experimental Medicine and Pathology, University 'La Sapienza', Rome, Italy
pp. 85-85(1)

In peritoneal macrophages of ovariectomized mice the expression of the human CETP gene diminishes the uptake of 3H-cholesteryl oleoyl ether acetylated LDL and, together with estrogen treatment, increases the ¹⁴C efflux rate from cells pre-loaded with acetylated ¹⁴C-cholesteryl ester LDL - P.M. Cazita¹, L.M. Harada¹, L. Asakura¹, H.C.F. Oliveira², E.C.R. Quintao¹. ¹Lipid Laboratory (LIM 10), University of Sao Paulo Medical School; ²Department of Physiology and Biophysics, Institute of Biology, State University of Campinas, Sao Paulo, Brazil
pp. 86-86(1)

CD14 C(-260)>T gene polymorphism is not a risk factor for myocardial infarction - M.T. Longombardo¹, A.B. Cefalu'², G. Emmanuele¹, V. Valenti², F. Pezzino¹, C.M. Buglino², B. Fiore¹, C.M. Barbagallo², D. Noto², M.C. Mazzarino¹, M. Rizzo², A. Notarbartolo², S. Travali¹, M.R. Averna². ¹Department of Biomedical Sciences, University of Catania; ²Dipartimento di Medicina Clinica e delle Patologie Emergenti, University of Palermo, Italy
pp. 86-86(1)

Coronary heart disease risk assessment in diabetes mellitus: A comparison of Euro 98 and UK 99 charts - A. Cerghizan. Iuliu Hatieganu University, Cluj Napoca, Cluj. Romania
pp. 86-86(1)

The antiapoptotic effect of exogenous VEGF on serum starved endothelial cells is mediated via VEGFR-1 & VEGFR-2 - C.W.M. Chan¹, C. Imray², A. Ahmed³. ¹Selly Oak Hospital, Birmingham; ²Walsgrave Hospital, Coventry; ³University of Birmingham, UK
pp. 86-86(1)

Are 'stable' carotid plaques less prone to post-endarterectomy microembolisation? - C.W.M. Chan¹, C. Tiivas², G. Pritchard², D. Higman², C. Imray². ¹Selly Oak Hospital, Birmingham; ²Walsgrave Hospital, Coventry, UK
pp. 86-87(2)

Effect of atorvastation and fish oil on plasma high sensitive C-reactive protein, interleukin-6 and tumor necrosis factor-alpha levels in obese subjects - D.C. Chan, G.F. Watts, P.H.R. Barrett, L.J. Beilin, T.A. Mori. University of Western Australia, Perth, WA, Australia
pp. 87-87(1)

Combined effects of an HMG CoA reductase inhibitor and fish oil on apolipoprotein B-100 kinetics in visceral obesity - D.C. Chan, G.F. Watts, P.H.R. Barrett, T.A. Mori, L.J. Beilin, T.G. Redgrave. University of Western Australia, Perth, WA, Australia
pp. 87-87(1)

A factorial study of the effects of atorvastatin and fish oil on chylomicron remnant metabolism studied kinetically with a breath test in obese men - D.C. Chan, G.F. Watts, P.H.R. Barrett, T.A. Mori, T.G. Redgrave. University of Western Australia, Perth, WA, Australia
pp. 87-87(1)

Randomized controlled trial of the effect of n-3 fatty acids supplementation on apolipoprotein B-100 and chylomicron remnant metabolism in visceral obesity - D.C. Chan, G.F. Watts, T.A. Mori, P.H.R. Barrett, T.G. Redgrave, L.J. Beilin. University of Western Australia, Perth, WA, Australia
pp. 87-87(1)

Risk factors of negative stress test and angiographically insignificant coronary artery atherosclerosis - S.-H. Chan, J.-H. Chen. National Cheng-Kung University Hospital, Tainan City, Taiwan
pp. 87-88(2)

Effects of atorvastatin 10 mg on triglycerides in diabetics type 2 patients, a double blind randomized placebo controlled study - B. Chanu¹, C. Koch², J.J. Portal², H. Laouenan². ¹Medecine V, Hopital Henri Mondor, Creteil; ²Pfizer, Paris, France
pp. 88-88(1)

The lipid lowering effect of yogurt in patients with high total cholesterol level - T.H. Chao¹, J.H. Chen¹, M.-T. Lin², W.C. Tsai¹, Y.H. Li¹, P.Y. Liu¹. ¹Department of Internal Medicine, College of Medicine, National Cheng Kung University; ²Department of Biochemistry, College of Medicine, National Cheng Kung University, Tainan, Taiwan
pp. 88-88(1)

Induction of vascular endothelial cell apoptosis through the platelet-activating factor receptor in hypercholesterolemia - C.-H. Chen, T. Jiang, J.-H. Yang, W. Jiang, H.J. Pownall, C.M. Ballantyne, J. Lu, P.D. Henry, C.-Y. Yang. Baylor College of Medicine, Houston, TX, USA
pp. 88-88(1)

Oxidized LDL-induced vascular endothelial cell apoptosis involves ceramide-mediated Akt dephosphorylation: Protective role of FGF2 overexpression - J. Lu¹, S. Suzuki², H.J. Safi², W. Jiang¹, P.D. Henry¹, J.-H. Yang¹, J.D. Morrisett¹, C.-H. Chen¹. ¹Baylor College of Medicine; ²University of Texas - Houston Medical School, Houston, TX, USA
pp. 88-89(2)

Internalization of the class A scavenger receptor is regulated by cytoplasmic domain - Q. Chen, X. Guan. Nanjing Medical University, Nanjing, China
pp. 89-89(1)

Elevated plasma C-reactive protein and protein S, but not von willebrand factor, V-CAM nor P-selectin levels, are associated with impaired endothelium dependent vascular reactivity in patients with coronary artery disease - R. Anderson, A. Dart, J.P.F. Chin-Dusting. Baker Medical Research Institute, Melbourne, Victoria, Australia
pp. 89-89(1)

Peroxisome proliferator-activated receptor alpha controls macrophage cholesterol homeostasis by reducing cholesterol esterification - G. Chinetti, S. Lestavel, J.-C. Fruchart, V. Clavey, B. Staels. UR 545 INSERM, Institut Pasteur de Lille and Lille II University, France
pp. 89-89(1)

Contribution of protease activated receptors to mast cell activity regulation - I.V. Chistov¹, T.N. Dugina¹, B.A. Umarova¹, E. Glusa², S.M. Strukova¹. ¹Department of Human Physiology, Faculty of Biology, Moscow State University of Moscow, Russia; ²Center of Vascular Biology and Medicine, University of Jena, Erfurt, Germany
pp. 89-89(1)

Insulin resistance as a marker of small dense LDL in Koreans - H.K. Cho¹, G.J. Shin¹, S.H. Park¹, Y. Jang², E.Y. Cho², D.J. Kim³, S.P. Day⁴, C.J. Packard⁴, J. Shepherd⁴, M.J. Caslake⁴. ¹Ewha Women's University, Seoul; ²Cardiovascular Genome Center, Yonsei University Medical Center, Seoul; ³Endocrinology Department, Ilsan Hospital, Koyang, Korea; ⁴Department of Pathological Biochemistry, Glasgow Royal Infirmary, Glasgow, UK
pp. 89-90(2)

The distributions of blood lipids, lipoprotein LP(A), C-reactive protein, homocysteine, fibrinogen, apolipoproteins A-I and B, by sex: The ATTICA study - C. Chrysohoou, D. Panagiotakos, C. Pitsavos, J. Skoumas, M. Toutouza, I. Papaioannou, A. Zeimbekis, C. Stefanadis, P. Toutouzas. Department of Cardiology, School of Medicine, University of Athens, Greece
pp. 90-90(1)

Mediterranean diet, and its association with clinical and biochemical markers related to cardiovascular risk: The attica study - C. Chrysohoou, C. Pitsavos, J. Skoumas, D. Panagiotakos, M. Toutouza, I. Papaioannou, A. Zeimbekis, C. Stefanadis, P. Toutouzas. Department of Cardiology, School of Medicine, University of Athens, Greece
pp. 90-90(1)

Plasma homocysteine levels in relation to several cardiovascular risk factors: The attica study - C. Chrysohoou, C. Pitsavos, J. Skoumas, D. Panagiotakos, A. Zeimbekis, M. Toutouza, I. Papaioannou, C. Stefanadis, P. Toutouzas. Department of Cardiology, School of Medicine, University of Athens, Greece
pp. 90-90(1)

The association between abdominal obesity, inflammatory markers and lipids levels, in the general population: The attica study - C. Chrysohoou, C. Pitsavos, J. Skoumas, D. Panagiotakos, M. Toutouza, I. Papaioannou, A. Zeimbekis, C. Stefanadis, P. Toutouzas. Department of Cardiology, School of Medicine, University of Athens, Greece
pp. 90-90(1)

Role of neutrophils in oxidized LDL mediated injury of endothelial cells - K.-J. Chun, S.-M. Son, I.-J. Kim, T.-J. Hong, Y.-K. Kim, Y.-W. Shin. Department of Internal Medicine, Pusan National University Hospital, South Korea
pp. 91-91(1)

The difficulty to evaluate the global cardio- and cerebro-vascular risk in FCH patients: A didactic case report with early total occlusion of the right carotid - A.F.G. Cicero, S. Linarello, M.P. Panourgia, S. Nascetti, A. Gaddi. Atherosclerosis Study Centre 'G. Descovich', Bologna, Italy
pp. 91-91(1)

Palatability and acceptability of a low dose soy protein/-sitosterol association as cholesterol lowering agent - A.F.G. Cicero, M.P. Panourgia, A. Fiorito, S. D'Addato, A. Gaddi. Atherosclerosis Study Centre 'G. Descovich', Bologna, Italy
pp. 91-91(1)

Distribution of antibodies against oxidized LDL plasma level in a wide sample of healthy subjects: The brisighella heart study - A.F.G. Cicero, Z. Sangiorgi, M. Leoni, E. Grandi, A. Dormi, A. Gaddi. Atherosclerosis Study Centre 'G. Descovich', Bologna, Italy
pp. 91-91(1)

Uric acid is an independent risk factor for cardiovascular disease? The brisighella heart study - S. D'Addato, A.F.G. Cicero, A. Dormi, Z. Sangiorgi, S. Nascetti, A. Gaddi. Atherosclerosis Study Center, Bologna, Italy
pp. 91-92(2)

6-Months follow-up of 105 women treated with soy isoflavones because of a climacteric syndrome - O. Iommelli², A.F.G. Cicero¹, G. Tommasillo³. ¹Atherosclerosis Study Centre 'G. Descovich', Bologna; ²Acupuncture and Phytotherapy Service, ³Gynecology and Obstetric Unit, San Paolo Hospital, Napoli, Italy
pp. 92-92(1)

Sex-related differences in cardiovascular risk factors among serious depressive patients: Preliminary results of the PPHSS - A.F.G. Cicero¹, M. Forghieri², F. Cipressi², R. Arletti³. ¹Atherosclerosis Centre 'G. Descovich', Bologna; ²Neuropsychiatric Health Care Home Villa Rosa; ³Biomedical Science Department, Pharmacology Section, Modena, Italy
pp. 92-92(1)

Simvastatin stabilizes atherosclerotic plaques by inhibiting cyclooxygenase-2 dependent metalloproteinase activity - F. Cipollone, M. Fazia, A. Iezzi, M. Zucchelli, D. De Cesare, B. Pini, S. Ucchino F. Spigonardo, G. Bajocchi, F. Chiarelli, M. Bucci, F. Cuccurullo, A. Mezzetti. University of Chieti 'G. D'Annunzio' School of Medicine, Chieti, Italy
pp. 92-92(1)

Effect of a high protein, energy restricted diet on body composition, insulin sensitivity and lipid levels in hyperinsulinemic subjects - N.D. Luscombe¹, M. Noakes², G. Wittert³, E. Farnsworth², E. Argyiou², P.M. Clifton². ¹University of Adelaide, Department of Physiology; ²CSIRO Health Science and Nutrition; ³University of Adelaide, Department of Medicine, Australia
pp. 92-92(1)

Plasma ApoE production is reduced by atorvastatin treatment in patients with combined hyperlipidemia - J.S. Cohn¹, M. Tremblay¹, R. Batal¹, H. Jacques¹, L. Veilleux¹, C. Rodriguez¹, P.H.R. Barrett², D. Dubreuil¹, M. Roy¹, L. Bernier¹, O. Mamer³, J. Davignon¹. ¹Clinical Research Institute of Montreal, Quebec, Canada; ²University of Washington, WA, USA; ³McGill University, Montreal, Canada
pp. 93-93(1)

Mediterrasian - The best cardioprotective cuisine - D. Colquhoun. Core Research, Brisbane, Queensland, Australia
pp. 93-93(1)

Mediterranean and low fat diets are associated with similar lipid levels at 1 year in patients with coronary heart disease on statin therapy - D. Colquhoun¹, P. Glasziou², S. Somerset¹, S. Pirozzo², P. Horsley¹, K. Irish¹, J. Weyers¹. ¹Core Research Group; ²University of Queensland, Brisbane, Queensland, Australia
pp. 93-93(1)

Autonomic nervous system arousal and the frequency of angina attacks - E.S. Strodl¹, D. Colquhoun², C. Aroney³, J. Kenardy¹. ¹University of Queensland; ²Core Research; ³Prince Charles Hospital, Brisbane, Queensland, Australia
pp. 93-93(1)

Risk factors for atherosclerosis are present in patients with asymptomatic aortic stenosis - P. Das¹, H. Rimington¹, P.J. Lumb², M.A. Crook², A.S. Wierzbicki². ¹Department of Cardiology, ²Department of Chemical Pathology, St. Thomas' Hospital, London, UK
pp. 93-94(2)

Measuring effects on intima media thickness: An evaluation of rosuvastatin - The meteor study - J.R. Crouse¹, D.E. Grobbee², D.H. O'Leary³, J.J.P. Kastelein⁴, M.L. Bots², G.W. Evans¹, M.K. Palmer⁵, J.S. Raichlen⁶. ¹Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA; ²University Medical Center Utrecht, The Netherlands; ³New England Medical Center, Boston, MA, USA; ⁴Academic Medical Center, Amsterdam, The Netherlands; ⁵AstraZeneca, Macclesfield, Cheshire, UK; ⁶AstraZeneca, Wayne, PA, USA
pp. 94-94(1)

MTHFR Polymorphism in patients with stroke and deep venous thrombosis - M. Cubrilo-Turek¹, E. Topic², A. Begonja², M. Stefanovic², A.-M. Simundic², V. Demarin³. ¹Sveti Duh General Hospital, ²Clinical Institute of Chemistry, ³Department of Neurology, School of Medicine, University of Zagreb and Sestre Milosrdnice, Zagreb, Croatia
pp. 94-94(1)

Effects of thiazolidinediones on proliferation and proteoglycan biosynthesis in human vascular smooth muscle cells - S.T. de Dios^1,3, G.L.R. Jennings^2,3, P.J. Little^1,3. ¹Cell Biology of Diabetes Laboratory, Baker Medical Research Institute; ²Baker Medical Research Institute; ³Monash University, Melbourne, Victoria, Australia
pp. 94-94(1)

Pathophysiological role of lipid peroxidation in patients with acute and chronic coronary syndromes - E. De Fanti¹, M. Rugolotto², A. Fasolin¹, E. Visentin², M. Barbiero², G. Rigatelli², R. Schiavon¹. ¹Laboratory Medicine, ²Cardiovascular Department, Legnago Hospital, Legnago (Verona), Italy
pp. 94-95(2)

Carotid and femoral intima-media thickness in normotensive adult patients succesfully operated for aortic coarctation - J. Vriend¹, E. De Groot¹, J. Kastelein¹, B. Mulder¹, H. Vliegen², G. Veen³, W. Stok¹, D. Samson¹. ¹Department of Vascular Medicine, Academic Medical Centre Amsterdam; ²Leiden University Medical Centre, Leiden; ³Free University Medical Centre, Amsterdam, The Netherlands
pp. 95-95(1)

Tissue incorporation of plant sterols and stanols in ApoE3* Leiden mice - A. De Jong¹, J. Plat¹, O.L. Volger², H.M.G. Princen², L.M. Havekes², R.P. Mensink¹. ¹Maastricht University, Department of Human Biology, Maastricht; ²TNO Prevention and Health, Gaubius Laboratory, Leiden, The Netherlands
pp. 95-95(1)

Early statin therapy induces complete normalization of endothelial dysfunction in children with familial hypercholesterolemia - S. De Jongh¹, M.R. Lilien², J. Op 't Roodt², E.S.G. Stroes¹, H.D. Bakker¹, J.J.P. Kastelein². ¹Department of Vascular Medicine, Academic Medical Center, Amsterdam; ²Wilhelmina Children's Hospital, Utrecht; ³Emma Children's Hospital, Academic Medical Center, Amsterdam, The Netherlands
pp. 95-95(1)

Rationale, design, and baseline characteristics of a clinical trial evaluating safety and efficacy of simvastatin in children with familial hypercholesterolemia - S. De Jongh¹, A.F.H. Stalenhoef³, M.B. Tuohy⁴, M. Mercuri⁴, H.D. Bakker², J.J.P. Kastelein¹. ¹Department of Vascular Medicine; ²Emma Children's Hospital, Academic Medical Center, Amsterdam; ³Department of Medicine, University Medical Center, Nijmegen, The Netherlands; ⁴Merck Research Laboratories, Rahway, NJ, USA
pp. 95-95(1)

The hypotriglyceridemic effect of pravastatin is associated with a decrease in serum apo-E concentration in our hyperlipemic population - M. De Oya¹, I. Campo², E. Viturro¹, B. Cano¹, M. Benavente¹, R. Rubio¹, C. Garces¹. ¹Fundacion Jimenez Diaz; ²Centro de Salud de Las Rozas, Madrid, Spain
pp. 96-96(1)

Carriers of the &unknown;3&unknown;4 apoE genotype display less susceptibility to in vitro oxidation of LDL - M. De Oya¹, R. Rubio¹, H. Ortega², M. Benavente¹, E. Viturro¹, B. Cano¹, D. Gomez-Coronado², M.A. Lasuncion², C. Garces¹. ¹Fundacion Jimenez Diaz; ²Hospital Ramon y Cajal, Madrid, Spain
pp. 96-96(1)

Paraoxonase-1 gene expression: The importance of the T(-107)C promoter polymorphism, and a role for transcription factors Sp1 and SREBP - I. Leviev, S.P. Deakin, M.-C. Brulhart, R.W. James. University Hospital, Geneva, Switzerland
pp. 96-96(1)

Two novel polymorphisms of the LDL-receptor gene in Greek patients with familial hypercholesterolemia - G. Dedoussis¹, C. Pitsavos², J. Skoumas², G. Sokari¹, M. Prassa¹, C. Stefanadis², P. Toutouzas². ¹Department of Diet and Nutrition, Harokopio University of Athens; ²Department of Cardiology, Hippocratio Hospital, Medical School of Athens, Greece
pp. 96-96(1)

Familial defective apolipoprotein B-100 versus familial hypercholesterolemia: An assessment of risk - S.W. Fouchier¹, E.J.G. Sijbrands², J.J.P. Kastelein¹, J.C. Defesche¹. ¹Department of Vascular Medicine, Academic Medical Centre, Amsterdam; ²Department of Internal Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands
pp. 96-97(2)

ABCA1 and atherosclerosis: Assessment by cholesterol efflux and IMT measurements - J.C. Defesche¹, J.J.P. Kastelein¹, K. Hovingh¹, E. De Groot¹, S.M. Clee², A.H. Zwinderman³, M.R. Hayden². ¹Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, The Netherlands; ²Center for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada; ³Department of Clinical Epidemiology and Biostatistics, Academic Medical Centre, University of Amsterdam, The Netherlands
pp. 97-97(1)

Nuclear 3-phosphoinositide metabolism and vascular smooth muscle cells proliferation - P. Deleris, D. Bacqueville, B. Perret, M. Breton-Douillon. INSERM U563, LML, Hopital Purpan, Toulouse, France
pp. 97-97(1)

Oleic, linoleic and alpha-linolenic acids from combined vegetable oils: Where are the limits for beneficial effects on lipemia in humans? - B. Delplanque¹, F. Mendy², B. Le Roy¹, E. Fenart², P. Boulos³, N. Combe⁴, A. Thaminy¹, F. Syeda¹, A. Ruelland¹. ¹Universite Paris Sud, Orsay; ²ONIDOL-CETIOM, Paris; ³LESIEUR, Neuilly; ⁴Universite Bordeaux-I, France
pp. 97-97(1)

Plasma lipid and apolipoprotein changes after weight loss in obese children - A. Thaminy¹, B. Delplanque¹, B. Le Roy¹, A. Ruelland¹, M-F. Rolland-Cachera², H. Thibault², D. Soulie³, P. Carbonel³, M. Deheeger², P. Serog³, P. Boulos⁴. ¹Universite Paris Sud, Orsay; ²INSERM, ISTNA, CNAM, Paris; ³'Les Oiseaux', Sanary/Mer; ⁴LESIEUR, Neuilly, France
pp. 97-97(1)

The effect of a low dose vitamin E versus an increased dose polyunsaturated fat from conception onwards on atherogenesis in LDLR-/- mice - P.N. Demacker, P. Van Heijst, L.J. Van Tits, A.F. Stalenhoef. Department of General Internal Medicine, University Medical Center, Nijmegen, The Netherlands
pp. 98-98(1)

The mechanism of intravascular transfer of lipids: Intralipid infusion in normal and parenterally fed patients - P.N. Demacker¹, M.P. Hectors¹, A.J. Naber². ¹Department of General Internal Medicine, ²Department of Gastroenterology, University Medical Center, Nijmegen, The Netherlands
pp. 98-98(1)

The PPAR agonists and the jagged/notch expression in differentiating to endothelium progenitor CD 34+ and HUVEC cells - A. Dembinska-Kiec, A. Polus, J. Grzybowska. Department of Clinical Biochemistry, Jagiellonian University, Krakow, Poland
pp. 98-98(1)

The effect of peroxisome proliferator-activated receptor-gamma2 (PPAR2) Pro12Ala variant on hypertension, glucose and lipid tolerance in the offsprings of families with familiar obesity in south of Poland - A. Dembinska-Kiec, I. Wybranska, M. Malczewska-Malec, I. Leszczynska-Golabek, B. Kiec-Wilk, A. Jabrocka, M. Kwasniak, M. Motyka. Department of Clinical Biochemistry, Jagiellonian University, Krakow, Poland
pp. 98-98(1)

High density lipoprotein and oxidized lipids as the modulators of platelet receptor activity - J. Hartwich¹, M. Motyka¹, A. Gruca¹, M. Bzowska², J. Skrzyczynska², G. Schmitz³, N. Leitinger⁴, A. Dembinska-Kiec². ¹Collegium Medicum, ²Institute of Molecular Biology, Jagiellonian University, Cracow, Poland; ³University of Regensburg, Germany; ⁴University of Vienna, Austria
pp. 98-98(1)

PPAR, leptin and endothelial cell mediated angiogenesis - A. Polus, E. Piatkowska, A. Dembinska-Kiec. Department of Clinical Biochemistry, Collegium Medicum, Jagiellonian University, Krakow, Poland
pp. 99-99(1)

Experimental and in vivo stimulation of LDL receptor expression in atorvastatin treated patients with heterozygous familial hypercholesterolemia by LDL-immunoapheresis - K. Derfler, M. Jansen, J. Streicher. University of Vienna, Austria
pp. 99-99(1)

Capillary isotachophoresis study of hypertriglyceridemia-induced changes in charge profile of human plasma lipoproteins - A.D. Dergunov¹ A. Hoy², S. Visvikis², G. Siest². ¹National Research Centre for Preventive Medicine, Moscow, Russia; ²INSERM, Nancy, France
pp. 99-99(1)

Interactions between exchangeable apolipoproteins in solution and in lipid-bound form - A.D. Dergunov¹, S. Visvikis², G. Siest². ¹National Research Centre for Preventive Medicine, Moscow Russia; ²INSERM, Nancy, France
pp. 99-99(1)

Comparison between diet, orlistat and fluvastatin in obese patients with mild hypertension and hypercholesterolemia - G. Derosa, A. Mugellini, L. Ciccarelli, G. Crescenzi, M. Ghelfi, R. Fogari. Department of Internal Medicine and Therapeutics, University of Pavia-IRCCS Policlinico S. Matteo, Pavia, Italy
pp. 99-100(2)

Efficacy of fluvastatin together with fenofibrate in hypercholesterolemic, type 2 diabetic subjects compared to monotherapy - G. Derosa, A. Mugellini, L. Ciccarelli, G. Crescenzi, M. Ghelfi, R. Fogari. Department of Internal Medicine and Therapeutics, University of Pavia-IRCCS Policlinico S. Matteo, Pavia, Italy
pp. 100-100(1)

Maternal and neonatal lipoprotein concentrations are inversely influenced by maternal SST1 polymorphism of apoCIII - O.S. Descamps^1,2, M. Bruniau¹, P.-F. Guilmot³, F.R. Heller². ¹Center for Medical Research at Jolimont, ²Department of Internal Medicine, ³Department of obstetrics and Gynecology, Centre Hospitalier Jolimont-Lobbes, Haine Saint-Paul, Belgium
pp. 100-100(1)

The neonatal cholesterol concentration is reduced not only in presence of apoE2 allele in neonates but also in presence of apoE2 in their mothers - O.S. Descamps^1,2, M. Bruniau¹, P.-F. Guilmot³, F.R. Heller². 1Center for Medical Research at Jolimont, ²Department of Internal Medicine, ³Department of Obstetrics and Gynecology, Centre Hospitalier Jolimont-Lobbes, Haine Saint-Paul, Belgium
pp. 100-100(1)

Statins regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells - W. Dichtl¹, J. Dulak¹, M. Frick¹, S.P. Schwarzacher¹, M.P.S. Ares², J. Nilsson², O. Pachinger¹, F. Weidinger¹. ¹Universitaetsklinik Innere Medizine, Abteilung Kardiologie, Innsbruck, Austria; ²Wallenberg Laboratory, MAS, University of Lund, Malmoe, Sweden
pp. 100-100(1)

Significance of the level of small dense LDL in diabetic patients - M. Djeric, O. Brkljac, S. Kojic-Damanjanov, Lj. Lepsanovic. Department of Pathophysiology and Laboratory Diagnostics, Clinical Centre, Novi Sad, Yugoslavia
pp. 100-101(2)

EWA study: Effects of hormone-replacement therapy on plasma concentrations of Lp(a) lipoprotein and TGF-1 - S. Djurovic¹, A. Westheim², K. Berg¹, I. Os². 1Department of Medical Genetics, ²Department of Internal Medicine, Ulleval University Hospital, Oslo, Norway
pp. 101-101(1)

Metabolic syndrome in patients with premature ischemic heart disease - L.M. Dobordginidze, N.A. Gratsiansky, A.B. Dobrovolsky, V.P. Masenko, M.V. Konnov. Center for Atherosclerosis, IPCM, Moskow, Russia
pp. 101-101(1)

Plasma TFPI and LP(a) levels in coronary artery disease - N. Domanic¹, D. Bilgen², H. Sonmez², C. Gurel³, H. Ekmekci², Z. Ozturk², A.S. Demir¹, T. Ulutin³, V.A. Vural¹, E. Kokoglu². ¹Department of Cardiology, ²Department of Biochemistry, ³Department of Genetic and Teratology Research Center, School of Medicine, Istanbul University, Turkey
pp. 101-101(1)

Platelet and plasminogen system activity in patients with different characteristics of acute coronary syndrome - O.R. Dotsenko, V.Z. Netiazhenko, I.V. Melnik, T.v. Kozmyk. National Medical University, Kyiv, Ukraine
pp. 101-101(1)

Exogenous short chain ceramide and sphingosine induce intracellular ceramide formation and modulate apo AI-ABCA1 dependent lipid efflux - W. Drobnik, G. Liebisch, B. Lieser, R. Schifferer, G. Schmitz. Institute of Laboratory Medicine and Clinical Chemistry, University of Regensburg, Germany
pp. 102-102(1)

Homocysteine decreases endothelin-1 expression by interfering with the AP-1 signaling pathway - S. Drunat^1,2, N. Moatti^1,2, J.-L. Paul^1,2, K. Demuth^1,2. ¹Biochimie Cardio-Vasculaire, Hopital Europeen G. Pompidou, Paris; ²Biochimie Appliquee, Faculte de Pharmacie, Chatenay-Malabry, France
pp. 102-102(1)

Effect of low dose simvastatin on carotid atherosclerosis progression in NIDDM patients with hyperlipidaemia - N.V. Dubyanskaya, K.M. Yafasov, N.Z. Sirojiddinova. Institute of Endocrinology, Tashkent, Uzbekistan
pp. 102-102(1)

Low hepatic lipase activity is a novel risk factor for coronary artery disease - K.A. Dugi¹, K. Brandauer¹, N. Schmidt¹, B. Nau¹, J.G. Schneider¹, S. Mentz¹, T. Keiper¹, J.R. Schaefer², M.L. Bahner³, J. Kreuzer⁴. ¹Internal Medicine I, Heidelberg University; ²Department of Cardiology, Philipps University, Marburg; ³Department of Radiology, Heidelberg University; ⁴Internal Medicine III, Heidelberg University, Germany
pp. 102-102(1)

One-year experience with the DALI LDL apheresis system - R. Durst¹, D. Rund², D. Schurr¹, O. Eliav¹, D. Ben-Yehuda², S. Shpizen¹, L. Ben-Avi¹, T. Schaap², F. Pelz², E. Leitersdorf¹. ¹Department of Internal Medicine B and The Center for Research, Prevention and Treatment of Atherosclerosis, ²Department of Hematology, Hadassah University Hospital, Jerusalem, Israel
pp. 102-103(2)

The acute effect of ethanol exposure on HDL cholesterol - Y. Neumark¹, Y. Friedlander¹, R. Durst², D. Jaffe¹, E. Butbul², E. Leitersdorf². ¹Braun School of Public Health, Hebrew University of Jerusalem; ²Center for Research, Prevention and Treatment of Atherosclerosis, Hadassah University Hospital, Jerusalem, Israel
pp. 103-103(1)

Coronary heart disease mortality decline and infectious diseases in the Czech population - A. Dvorakova, R. Poledne. Centre for Experimental Cardiovascular Research, IKEM, Prague, Czech Republic
pp. 103-103(1)

Carbohydrate-deficient transferrin and homocysteine in patients with mixed hyperlipidemia - J. Dvorakova, L. Dubska, J. Hyanek, L. Taborsky. Department of Clinical Biochemistry, Hospital Na Homolce, Prague, Czech Republic
pp. 103-103(1)

Diet and metformin in the treatment of the abdominal obese patients - F. Dzgoeva. Russian Endocrinology Research Centre, Moscow, Russia
pp. 103-103(1)

Oxidative stress status in adults with diabetes mellitus - S.A. Dzhekova-Stojkova¹, M.A. Krstevska¹, G.L. Bosilkova¹, Z.G. Stojkova². ¹Department of Medical and Experimental Biochemistry, ²Department of Medical and Experimental Physiology, Medical Faculty, Skopje, Macedonia
pp. 103-104(2)

Lipid profile in obese and non-obese greek hypertensives - A.D. Efstratopoulos¹, S.M. Voyaki², S. Sasiakou¹, A. Baltas¹, L. Mourgos¹, V. Lekakis¹, M. Pagoni¹. ¹3rd Medical Department and Hypertension Unit of General of Athens, 'G. Gennimatas'; ²Hypertension Clinic of Elefsis General Hospital 'Thriasio', Athens, Greece
pp. 104-104(1)

Risk factors of atherosclerosis in children - A. Efthimiadis, E. Lefkou, D. Psirropoulos, A. Tsapas, V. Ioannidou, G. Kazinakis, N. Lefkos. Clinic for Lipid Disturbances, 2nd Department of Internal Medicine, Medical School of Aristotelian University, Hippokration Hospital, Thessaloniki, Greece
pp. 104-104(1)

Classical risk factors and their impact on acute myocardial infarction in Israel. Sub-analysis of the ACSIS 2000 study - A. Elis, M. Lishner. Department of Medicine, Meir Hospital, Kfar Saba and Sackler Faculty of Medicine, Tel-Aviv University, Israel
pp. 104-104(1)

Prospective evaluation of diabetic ischaemic heart disease by computed tomography: The predict study - R.S. Elkeles¹, M. Flather², M.D. Feher³, I. Godsland¹, W. Richmond¹, S.E. Humphries⁴, M.B. Rubens⁵, S.R. Underwood⁶. ¹Unit for Metabolic Medicine, St. Mary Hospital; ²Clinical Trials and Evaluation Unit, Royal Brompton Hospital; ³Beta Cell Unit, Chelsea and Westminster Hospital; ⁴Division of Cardiovascular Genetics, University College London; ⁵Department of Imaging, Royal Brompton Hospital; ⁶Department of Cardiac Imaging, Royal Brompton Hospital, London, UK
pp. 105-105(1)

Sex differences in the association of serum bilirubin concentration with risk of coronary artery disease - A. Hamwi¹, G. Endler¹, R. Sunder-Plassmann¹, M. Exner¹, K. Huber², C. Manngalter¹, O. Wagner¹. ¹Department of Medical and Chemical Laboratory Diagnostics, ²Department of Internal Medicine II, Division of Cardiology, University Vienna Medical School, Austria
pp. 105-105(1)

Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease? - G. Endler¹, M. Funk¹, D. Haering¹, W. Lalouschek², W. Lang², M. Mirafzal¹, O. Wagner¹, C. Mannhalter¹. ¹Department of Medical and Chemical Laboratory Diagnostics, ²Department of Neurology, University Vienna Medical School, Austria
pp. 105-105(1)

PPARGC1/PGC1 gene locus: Associations with obesity indices and diabetes risk - H. Esterbauer, H. Oberkofler, V. Linnemayr, B. Iglseder, M. Hedegger, P. Wolfsgruber, B. Paulweber, G. Fastner, F. Krempler, W. Patsch. Landeskliniken Salzburg, Krankenhaus Hallein, Austria
pp. 105-105(1)

The E-selectin S128R polymorphism is not a risk factor for coronary artery disease in patients suffering from diabetes mellitus - M. Exner¹, G. Endler¹, R. Sunder-Plassmann¹, M. Raith¹, K. Huber², R. Marculescu¹, C. Mannhalter¹, O. Wagner¹. ¹Department of Medical and Chemical Laboratory Diagnostics, ²Department of Internal Medicine II, Division of Cardiology, University Vienna Medical School, Austria
pp. 106-106(1)

Genistein inhibits CRP-induced E-selectin induction in human aortic endothelial cells - M. Exner¹, M. Raith¹, B. Gmeiner², O. Wagner¹, S. Kapiotis¹. ¹Department of Medical and Chemical Laboratory Diagnostics, ²Department of Medical Chemistry, University of Vienna, Austria
pp. 106-106(1)

Heme oxygenase-1 genotype and restenosis after femoropopliteal PTA: A novel vascular protective factor - M. Exner¹, M. Schillinger², E. Minar², W. Mlekusch², M. Muellner³, C. Mannhalter¹, F.H. Bach⁴, O. Wagner¹. ¹Department of Medical and Chemical Laboratory Diagnostics, ²Department of Angiology, ³Department of Emergency Medicine, University of Vienna, Austria; ⁴Harvard Medical School, Boston, MA, USA
pp. 106-106(1)

Lipoprotein(a) is associated with angiographic restenosis after coronary stenting - M.V. Ezhov, Y.G. Matchin, A.P. Savchenko, O.I. Afanasieva, T.Y. Polevaya, V.G. Naumov, S.N. Pokrovsky. Cardiology Research Center, Moscow, Russia
pp. 106-106(1)

Guidelines for the prevention of atherosclerotic diseases. A European view - O. Faergeman. Aarhus Amtssygehus University Hospital, University of Aarhus, Denmark
pp. 106-107(2)

Insulin and other atherosclerotic risk factors in a Portuguese population at cardiovascular risk - L.L. Faleiro¹, M.C. Martins², M.O. Rodrigues², M.T. Seixas², A.E. Fonseca². ¹Departamento de Cardiologia IPR, Lisboa; ²Instituto Nacional de Saude, Lisboa, Portugal
pp. 107-107(1)

Atherogenicity of lipoprotein lipase in transgenic rabbits - J. Fan¹, T. Ichikawa¹, H. Unoki¹, J. Liang¹, T. Koike¹, S. Kitajima², T. Watanabe². ¹University of Tsukuba; ²Saga Medical School, Saga, Japan
pp. 107-107(1)

Probucol inhibition of ABCA1-mediated cellular lipid efflux - E. Favari¹, F. Bernini¹, G.H. Rothblat², G. Kellner-Weibel². ¹University of Parma, Italy; ²The Children's Hospital of Philadelphia, PA, USA
pp. 107-107(1)

Growth hormone could have a role in essential hypertension. Its relationship with circadian blood pressure profile and insulin resistance - C.A. Feldstein, D. Garrido, M. Akopian, A. Renauld, A.O. Olivieri, A. Zavala. Hypertension Program, Hospital de Clinicas San Martin and Barcelo Foundation, Buenos Aires, Argentina
pp. 107-107(1)

Immunisation with bacillus calmette-guerin (BCG) vaccine enhances aortic atherosclerosis in the chronic low level hypercholesterolaemic rabbits - W. El-Sankary, M. Tickner, D.J. Lamb, S. Hourani, L.-J. Eales, G.A.A. Ferns. University of Surrey, School of Biomedical and Life Sciences, Guildford, Surrey, UK
pp. 108-108(1)

Dietary copper deficiency decreases monocyte expression of CD11b (MAC-1) in normocholesterolaemic rabbits - D.J. Lamb¹, G.A.A. Ferns^1,2. ¹University of Surrey; ²Royal Surrey County Hospital, Guildford, Surrey, UK
pp. 108-108(1)

Identification of the proteoglycan binding site in apolipoprotein B48 - C. Flood, M. Gustafsson, J. Boren. Goteborg University, Gothenburg, Sweden
pp. 108-108(1)

High density lipoprotein cholesterol and myocardial infarction extent - M. Fonda¹, A.M. Semolic¹, A. Pagnin¹, L. Vitali-Serdoz¹, P. Gori², G. Sinagra², L. Cattin¹. ¹Atherosclerosis Research Center, Dipartimento di Scienze Cliniche, Morfoligiche e Tecnologiche, Clinica Medica, Universita' di Trieste, Ospedale di Cattinara; ²Division of Cardiology, Ospedale Maggiore, Trieste, Italy
pp. 108-108(1)

Influence of beta 2 and beta 3 receptors gene polymorphism on cardiovascular risk: A case-control study - L. Forga¹, M. Corbalan³, M. Palacios², A. Rivero², A. Marti³, J.A. Martinez³. ¹Endocrinology Department, ²Clinical Chemistry Department, Hospital of Navarra; ³Physiology and Nutrition, University of Navarra, Pamplona, Navarra, Spain
pp. 108-109(2)

The molecular basis of familial hypercholesterolemia in the Netherlands - S.W. Fouchier, M.A.W. Umans-Eckenhausen, J.J.P. Kastelein, J.C. Defesche. Academic Medical Centre at The University of Amsterdam, Department of Vascular Medicine, Amsterdam, The Netherlands
pp. 109-109(1)

The HMG-CoA reductase inhibitors prevents AT1 receptor gene overexpression in human vascular smooth muscle cells and endothelial cells stimulated with Kappa-elastin - T.M. Francuz, E. Kotrys-Puchalska, T. Jurczak, T. Gawlik, J.G. Gminski. Silesian Medical Academy, Katowice, Poland
pp. 109-109(1)

sVCAM-1, sICAM-1 and VWF factor in patients with diabetic retinopathy - T.M. Francuz¹, A. Telega², M. Syzdol¹, K. Siemianowicz¹, J.G. Gminski¹. ¹Silesian Medical Academy; ²Diabetic Outpatient Department, Katowice, Poland
pp. 109-109(1)

Antioxidant status in patients with diabetic retinopathy - T.M. Francuz¹, A. Telega², A. Wojcik¹, B. Posielezna¹, J.G. Gminski¹, K. Siemianowicz¹. ¹Silesian Medical Academy; ²Diabetic Outpatient Department, Katowice, Poland
pp. 109-109(1)

Possible role of statins as an adjuvant therapy in cancer - P. Fraunberger, B. Siegele, A. Heim, D. Seidel, A.K. Walli. Institute for Clinical Chemistry, Klinikum Grosshadern, Munich, Germany
pp. 110-110(1)

Autonomic nervous system influence on pulse pressure in mild non-treated hypertension - J. Freitas, R. Santos, M. Carvalho, A. Falcao De Freitas. Centro de Estudos da Funcao Autonomica, Faculdade de Medicina do Porto, Portugal
pp. 110-110(1)

Role of nuclear receptors in lipoprotein metabolism - J.C. Fruchart. Institut Pasteur de Lille, INSERM U545, Universite de Lille II, France
pp. 110-110(1)

Acute phase reduction of Lp(a) predicts restenosis in patients with acute myocardial infarction performed primary percutaneous transluminal coronary angioplasty - A. Fujino¹, T. Watanabe¹, K. Taira¹, K. Ashikawa¹, Y. Maruyama². ¹Yonezawa City Hospital, Yonezawa, Yamagata; ² Fukushima Medical University, Fukushima, Japan
pp. 110-110(1)

T lymphocyte functions mediated by oxLDL in relation to atherosclerosis - T. Fulop, N. Douxiech, A. Larbi, A. Khalil. Institut Universitaire de Geriatrie de Sherbrooke, Departement de Medecine, Faculte de Medecine, Universite de Sherbrooke, Quebec, Canada
pp. 111-111(1)

Modulation of NO production by oxLDL of various origin in HUVEC - A. Larbi¹, A. Khalil¹, T. Fulop¹, M. David-Dufilho², A. Brunet², M.-A. Devynck². ¹Institut Universitaire de Geriatrie de Sherbrooke, Universite de Sherbrooke, Sherbrooke, Quebec, Canada; ²Laboratoire de Recherche CardioVasculaire, CNRS, Faculte de Medecine, Necker, Paris, France
pp. 111-111(1)

Analysis and study of sudden cardiac deaths due to atherosclerosis, in the county of Trikala, Greece - T. Galeas¹, I. Hatzizisis², H. Zisis¹, S. Mylonas¹, A. Papadopoulos¹. ¹General Hospital of Trikala; ²Rural Medical Office, Greece
pp. 111-111(1)

Pharmacological interference with intestinal bile acid transport reduces plasma cholesterol in LDL receptor/APOE deficiency - C. Galman¹, A.-M. Ostlund-Lindqvist², A. Bjorquist², L. Svensson², B. Angelin¹, M. Rudling¹. ¹Metabolism Unit, Center for Metabolism and Endocrinology, Department of Medicine and Molecular Nutrition Unit, Center for Nutrition and Toxicology, NOVUM, Karolinska Institute at Huddinge University Hospital, Stockholm; ²Molecular Biology, Cell Biology and Biochemistry, Astra Zeneca R&D, Molndal, Sweden
pp. 111-111(1)

PLTP expression in the central nervous system of rabbits - R. Gander¹, P. Eller¹, S. Kaser¹, I. Theurl¹, D. Walter², T. Sauper¹, A. Ritsch¹, J.R. Patsch¹, B. Foeger¹. ¹Department of Medicine, ²Department of Biochemical Pharmacology, University of Innsbruck, Austria
pp. 111-112(2)

Effects of various fibrates on serum alkaline phosphatase activity - E. Ganotakis¹, V. Tsimihodimos², E. Rizos², H. Milionis², V. Athyros², E. Bairaktari³, C. Seferiades³, M. Elisaf². ¹Department of Internal Medicine, Medical School, University of Crete, Heraklion; ²Department of Internal Medicine, Medical School, University of Ioannina; ³Laboratory of Biochemistry, School of Chemistry, University of Ioannina, Greece
pp. 112-112(1)

Serum lipid abnormalities in patients with acute myocardial infarction - D. Papakonstantinou¹, E. Alexopoulos¹, G. Vrentzos², J.A. Papadakis², E. Ganotakis². ¹Department of Cardiology, Rodos General Hospital, Rodos; ²Department of Internal Medicine, University Hospital of Crete, Heraklion, Greece
pp. 112-112(1)

Influence of birth weight on the apo E genetic determinants of plasma lipid levels in children - C. Garces¹, M. Benavente¹, H. Ortega², E. Viturro¹, B. Cano¹, M.A. Lasuncion², F. Rodriguez Artalejo¹, M. De Oya¹. ¹Fundacion Jimenez Diaz; ²Hospital Ramon y Cajal, Madrid, Spain
pp. 112-112(1)

ApoE genotype as a risk factor of myocardial infarction in young people - C. Garces, M. Benavente, E. Viturro, B. Cano, J. Romero, E. Martin, J. Farre, M. De Oya. Fundacion Jimenez Diaz, Madrid, Spain
pp. 112-113(2)

Comparison of the effect of PPAR, apo E2, LPL or LDL-receptor gene mutations on the cholesterol and triglyceride content of apoB containing lipoproteins (VLDL, IDL, LDL): Is there any clinical implication? - D. Brisson^1,2, M.-C. Vohl^3,4, P. Perron^1,2, T.J. Hudson^5,6, D. Gaudet^1,2. ¹Montreal University Community Genomic Medicine Center, ²Lipid Research Group, Chicoutimi Hospital; ³Lipid Research Center, CHUL; ⁴Food Science and Nutrition Department, Laval University; ⁵Montreal Genome Center, McGill University, Montreal, Quebec, Canada; ⁶Whitehead Institute/MIT Center For Genome Research, Cambridge, MA, USA
pp. 113-113(1)

Evaluation of an immunoturbidimetric assay for the determination of apolipoprotein B serum levels. Comparative analysis with a nephelometric method - A. Gavarro, E. Berlanga, F. Campos, F. Salceda, R. Ustrell, M. Torra. Udiat C.D. Laboratory, Sabadell, Barcelona, Spain
pp. 113-113(1)

Relationship between high LDL and persistent hypertension - D. Gavish, E. Leibovitz, D. Dicker, Y. Yosefi, R.J. Viskoper. For The IBPM Program, Israel
pp. 113-113(1)

In vivo metabolism of LDL-subfractions - H.C. Geiss¹, S. Bremer¹, P.H.R. Barrett², C. Otto¹, K.G. Parhofer¹. ¹Medical Department II, Klinikum Grosshadern, University of Munich, Germany; ²Department of Medicine, University of Western Australia, Perth, Australia
pp. 113-114(2)

Influence of atorvastatin on LDL-subtypes in patients with hypertriglyceridemia - H.C. Geiss, E. Laubach, P. Schwandt, K.G. Parhofer. Medical Department II, Klinikum Grosshadern, University of Munich, Germany
pp. 114-114(1)

Homocysteine and folate levels in patiens with proven coronary artery disease - M. Gellerman¹, Y.G. Assaraf³, A. Krivelevich¹, T. Snitkovsky², N. Roguin¹. ¹Department of Cardiology, Western Galilee Hospital, Nahariya; ²Department of Biology, Faculty of Medicine, Technion, Haifa; ³Biochemistry Laboratory, Western Galilee Hospital, Nahariya, Israel
pp. 114-114(1)

Blood homocysteine and kidney involvement in type one and type two diabetes mellitus - O. Giampietro, D. Calvi, G. Forotti, E. Boldrini, F. Marchini, L. Moretti, E. Matteucci. University of Pisa, Italy
pp. 114-114(1)

Lipoprotein(A) and BMI: Significant correlation with positive family history of cardiovascular diseases in obese, hypertensive and diabetic children - B. Glowinska¹, M. Urban¹, A. Koput². ¹2nd Department of Children's Diseases, ²Pediatrics Laboratory Department, Medical University, Bialystok, Poland
pp. 114-114(1)

Physical activity modulates the effect of APOE genotype on HDL-cholesterol concentrations in a spanish population - D. Corella¹, M. Guillen¹, D. Godoy², J.V. Sorli^1,2, O. Portoles¹, C. Saiz¹, O. Coltell³, J.M. Ordovas⁴. ¹Preventive Medicine Department. University of Valencia; ²Hospital General Universitario, Valencia; ³University Jaime I, Castellon, Spain; ⁴Human Nutrition Research Center at Tufts University, Boston, MA, USA
pp. 115-115(1)

Effect of the -3826A/G variant of the uncoupling protein-1 gene on obesity-related phenotypes in a population-based study in Spain - J.V. Sorli^1,2, D. Corella¹, M. Guillen¹, O. Portoles¹, A. Sabater¹, J.I. Gonzalez¹, S. Ruiz De La Fuente¹, D. Godoy². ¹Preventive Medicine Department, University of Valencia; ²Hospital General Universitario, Valencia, Spain
pp. 115-115(1)

Individual risk factor variation with time predicts clinical coronary heart disease - I.F. Godsland, Z. Efstathiadou, J.A.R. Jeffs, D.G. Johnston. Imperial College Faculty of Medicine, London, UK
pp. 115-115(1)

Two MMP2 gene promoter polymorphisms in chronic heart failure - A. Vasku¹, M. Goldbergova¹, L. Spinarova², J. Spinar², J. Toman². ¹Faculty of Medicine, ²St. Ann's Faculty Hospital, Masaryk University, Brno, Czech Republic
pp. 115-115(1)

Intron retinoic X receptor alpha polymorphism in chronic heart failure - M. Goldbergova¹, L. Spinarova², J. Spinar², J. Toman², A. Vasku¹. ¹Faculty of Medicine, ²St. Ann's Faculty Hospital, Masaryk University, Brno, Czech Republic
pp. 115-116(2)

Onset and severity of supravalvular aortic stenosis depend on age at beginning of LDL-apheresis in homozygous familial hypercholesterolemia - S. Gonbert, P. Benlian, E. Bruckert, F. Dairou, I. Atassi, I. Beucler, G. Turpin. La Pitie Hospital, Department of Endocrinology, Paris, France
pp. 116-116(1)

The -516 C allele in the apolipoprotein B100 promoter is associated with low lipid levels and with a low frequency of subclinical atherosclerosis in hypercholesterolemic patients - S. Gonbert^1,2, A. Sposito², G. Turpin¹, J. Chapman², J. Thillet¹. ¹Endocrinology Department, ²U551 INSERM, La Pitie Hospital, Paris, France
pp. 116-116(1)

Influence of waist to hip ratio (WHR) on diurnal triglyceride (TG) profiles as the expression of postprandial lipemia in familial hypercholesterolemia - C. Gonzalez¹, A. Rodrigo¹, J.T. Real¹, M. Castro-Cabezas², J.F. Ascaso¹, W. Erkelens², R. Carmena¹. ¹Endocrinology and Nutrition, Hospital Clinico, University of Valencia, Spain; ²University of Utrecht, The Netherlands
pp. 116-116(1)

Serum lipid levels and lipid lowering therapy in patients with coronary artery disease history: How much attention is being paid? Is the management sufficient? - A.D. Labrou, D.K. Theodoridis, A.N. Zagouti, S.K. Terzi, L.F. Borghi, O.E. Koutsogiannis, A.G. Savvopoulou, A.E. Panagiotidou, A.K. Gotsis. Cardiology Department, General Hospital of Komotini, Greece
pp. 116-117(2)

Ca2+ regulation of signal transduction in the endothelium - W.F. Graier. Department of Medical Biochemistry and Medical Molecular Biology, University of Graz, Austria
pp. 117-117(1)

LDL-cholesterol modulates the membrane binding and intracellular distribution of annexin 6 in CHO cells - F. Schwartz¹, P. Dauterstedt¹, I. De Diego², J. Heeren¹, U. Beisiegel¹, C. Enrich², T. Grewal¹. ¹Institute for Medical Biochemistry and Molecular Biology, University Hospial Eppendorf, Hamburg, Germany; ²IDIBAPS, Facultat de Medicina, Universitat de Barcelona, Spain
pp. 117-117(1)

Effect of mechanical stress on myocardial anti-oxidant enzymes and ischemic preconditioning in rabbit heart - A. Grover¹, R. Vijayvergiya¹, A. Bahl¹, D. Sharma², V.K. Bhargava², S. Majumdar³. ¹Department of Cardiology, ²Department of Pharmacology, ³Department of Experimental Medicine, PGIMER, Chandigarh, India
pp. 117-117(1)

Biochemical changes in in-situ cardiac myocytes at different stages of ischemic preconditioning in rabbit model - A. Grover¹, R. Vijayvergiya¹, D. Sharma¹, S. Majumdar³, V.K. Bhargava¹. ¹Department of Cardiology, ²Department of Pharmacology, PGIMER, Chandigarh, India
pp. 117-117(1)

Can discussing a patient's calculated coronary risk increase the effectiveness of dyslipidemia therapy? Preliminary results of the check-up study - S.A. Grover, I. Lowensteyn, L. Coupal, S. Marchand, M. Kaouache, C. Brewer. The Montreal General Hospital, Montreal, Quebec, Canada
pp. 118-118(1)

Reaching lipid targets following starting doses of statins in primary care: The results of the check-up study - S.A. Grover, I. Lowensteyn, M. Kaouache, S. Marchand, L. Coupal, C. Brewer. The Montreal General Hospital, Montreal, Quebec, Canada
pp. 118-118(1)

Cardiovascular reactivity to mental stress test, autonomic balance and baroreflex sensitivity in hypertensive patients - L. Guasti¹, D. Zanotta¹, L.T. Mainardi², C. Simoni¹, D. Garganico¹, C. Crespi¹, G. Gaudio¹, A. Maffiolini¹, A.M. Grandi¹, S. Cerutti², A. Venco¹. ¹Internal Medicine, University of Insubria, Varese; ²Department of Biomedical Engineering, Polytechnic University, Milano, Italy
pp. 118-118(1)

Reduction of postprandial accumulation and CETP-mediated remodelling of triglyceride-rich lipoprotein subspecies by atorvastatin in type IIB hyperlipidemia - M. Guerin¹, P. Egger¹, W. Le Goff¹, C. Soudant¹, R. Dupuis², M.J. Chapman^{1 1}Inserm U551; ²Pfizer, Paris, France
pp. 118-118(1)

Dose-dependent action of atorvastatin on CETP activity, atherogenic apoB-containing lipoproteins and cellular free cholesterol efflux in type IIB hyperlipidemia - M. Guerin¹, P. Egger¹, W. Le Goff¹, C. Soudant¹, A. Van Tol², R. Dupuis³, M.J. Chapman^{1 1}INSERM U551, Paris, France; ²Erasmus University, Rotterdam, The Netherlands; ³Pfizer, Paris, France
pp. 118-119(2)

Elevated CETP activity and enhanced cellular cholesterol efflux are key features of postprandial lipid metabolism in type IIB hyperlipidemia - M. Guerin¹, P. Egger¹, C. Soudant¹, W. Le Goff¹, A. Van Tol², R. Dupuis³, M.J. Chapman^{1 1}INSERM U551, Paris, France; ²Erasmus University, Rotterdam, The Netherlands; ³Pfizer, Paris, France
pp. 119-119(1)

The V249I polymorphism in the fractalkine receptor CX3CR1 is not associated with peripheral arterial disease - A. Gugl¹, W. Renner¹, G. Seinost¹, M. Brodmann¹, E. Pabst¹, T.C. Wascher², B. Paulweber³, B. Iglseder⁴, E. Pilger¹. ¹Division of Angiology, ²Department of Medicine, Medical University Klinik Graz; ³Department of Medicine, ⁴Department of Neurology, Landeskliniken Salzburg, Austria
pp. 119-119(1)

Effect of atorvastatin on autoantibodies against oxidized low-density lipoprotein in postmenopausal women with coronary heart disease - V.S. Gurevich¹, S.A. Urazgildeeva¹, L.V. Shatilina², M.M. Mnuskina³, L.V. Oganesyan³, I.N. Makarova³. ¹Mechnicov's State Medical Academy; ²Institute of Cardiology; ³City Central Laboratory Center, St. Petersburg, Russia
pp. 119-119(1)

Inheritance of cholesterol synthesis and absorption in families with coronary heart disease - H. Gylling, T.A. Miettinen. Department of Clinical Nutrition, University of Kuopio and Department of Medicine, University of Helsinki, Finland
pp. 119-119(1)

Apo B -100-defect in pediatric patients in Austria: Laboratory and clinical data - N. Hachemian, V. Kretzer, B. Schmidt, G. Kostner, K. Widhalm. Department of Pediatrics, Division of Neonatology Intensive Care and Inborn Errors, University of Vienna, Institute for Medical Biochemistry and Molecular Biology, University of Graz, Austria
pp. 120-120(1)

Lipoprotein(a) uptake by mesangial cells of the human kidney - M. Haiman¹, I. Leiter¹, L. Fineder¹, W. Salvenmoser², G. Bock³, F. Kronenberg¹, H. Dieplinger¹. ¹Institute for Medical Biology and Human Genetics, ²Institute for Zoology, ³Institute for Experimental Pathology, University of Innsbruck, Austria
pp. 120-120(1)

Evaluation of gender differences in thrombotic risk factors during lipid lowering therapy with atorvastatin - E. Hatzinikolaou, K. Klebetsanis, D. Tziakas, I. Papadopoulos, T. Iosifidis, G. Halikias, D. Hatseras. University of Thrace, Greece
pp. 120-120(1)

Atorvastatin limits the proinflammatory response of smooth muscle cell to thrombin - M. Haloui¹, O. Meilhac¹, H. Laouenan², J.-B. Michel¹. ¹U460 Inserm, Xavier Bichat; ²Pfizer, Paris, France
pp. 120-120(1)

Role of matrix metalloproteinases, cysteine proteases and their inhibitors in atherothrombosis: A molecular genetic approach - A. Hamsten. Karolinska Institute, Stockholm, Sweden
pp. 120-121(2)

The coronary heart disease risk in newly diagnosed type 2 diabetic persons - N.D. Hancu. Iuliu Hatieganu University, Cluj Napoca, Cluj, Romania
pp. 121-121(1)

Marked induction of sterol 27-hydroxylase (CYP27) activity and MRNA levels during differentiation of human cultured monocytes into macrophages - M.D. Hansson¹, E. Ellis², M.C. Hunt¹, G. Schmitz³, A. Babiker¹. ¹Division of Clinical Chemistry, ²Division of Gastroenterology and Hepatology, Karolinska Institutet Huddinge University Hospital, Stockholm, Sweden; ³Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany
pp. 121-121(1)

PPE-1-regulated endothelial-specific gene therapy using VEGF & PDGF-B induced angiogenesis and vessel maturation in ischemic limb model - A. Shaish¹, K. Levanon¹, N. Vardr-Bloom¹, S. Greenberger¹, I. Barshak², A. Orenstein³, E. Breitbart⁴, D. Harats^1,4. ¹The Institute of Lipid & Atherosclerosis Research; ²The Institute of Pathology; ³The Institute of Advanced Technologies; ⁴Vascular Biogencis, Ltd., Israel
pp. 121-121(1)

Altered expression of intermediate conductance calcium-activated potassium channels induced by long-term blockade of nitric oxide synthesis - H. Hasegawa¹, T. Saito¹, Y. Chiba¹, Y. Fujiwara¹, A. Shoji¹, H. Miura², M. Miura¹. ¹Akita University, Akita, Japan; ²Medical College of Wisconsin, MI, USA
pp. 121-121(1)

A flow cytometric procedure to measure functional LDL receptors for diagnosis of familial hypecholesterolemia - H. Hattori¹, M. Nagano¹, K. Kawamura¹, J. Ishii², M. Tsuji², F. Iwata³, T. Yamamura⁴, Y. Miyake⁴, T. Egashira¹, T. Okada³, N.E. Miller⁵, M. Emi⁶, A. Yamamoto⁴. ¹Research Department, R&D Center, BML, Kawagoe; ²Division of Internal Medicine, Hokaido Hospital for Social Health Insurance, Sapporo; ³Department of Pediatrics, Nihon University School of Medicine, Tokyo; ⁴Department of Etiology and Pathophysiology, National Cardiovascular Center Research Institute, Suita, Japan; ⁵Department of Cardiovascular Biochemistry, St Bartholomew's & The Royal London School of Medicine and Dentistry, London, UK; ⁶Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, Kawasaki, Japan
pp. 122-122(1)

Scavenger receptors present in the intestinal brush border membrane mediate the transport of cholesterol and other dietary lipids - H. Hauser, M. Werder, C.-H. Han, G. Schulthess. Institute of Biochemistry, Swiss Federal Institute of Technology, ETH Zurich, Switzerland
pp. 122-122(1)

Omapatrilat inhibits oxidative stress and atherosclerosis progression in apolipoprotein E deficient mice - T. Hayek^1,2, S. Hamoud², S. Keidar^1,2, E. Pavlotzky^1,2, R. Coleman⁴, M. Aviram^1,2,3, M. Kaplan^1,2. ¹The Lipid Research Laboratory, Bruce Rappaport Faculty of Medicine, Technion; ²Rambam Medical Center; ³Rappaport Family Institute for Research in the Medical Sciences; ⁴Department of Morphology, Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
pp. 122-122(1)

Endothelial-derived lipoprotein lipase is bound to human postprandial chylomicrons and mediates their hepatic clearance in vivo - J. Heeren¹, C. Bodman¹, A. Niemeier², M. Merkel³, U. Beisiegel¹. ¹IMBM, Department of Molecular Cell Biology; ²Institute of Orthopedics, ³Institute of Internal Medicine, Hamburg, Germany
pp. 122-122(1)

The scavenger receptor cysteine rich (SRCR) domain of human macrophage scavenger receptor A1 is involved in chemotaxis - H. Heider, M. Dobler, M. Hellsten. University of Basel, Institute of Biochemistry, Basel, Switzerland
pp. 122-123(2)

Mutations in the human ATP-binding cassette transporters ABCG5 and ABCG8 in sitosterolemia - S. Heimerl¹, T. Langmann¹, C. Moehle¹, R. Mauerer¹, M. Dean², F-U. Beil³, K. Von Bergmann⁴, G. Schmitz¹. ¹Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany; ²Human Genetics Section, Laboratory of Genomic Diversity, NCI-Frederick, Maryland, USA; ³IHF Institute for Hormone and Fertility Research, University of Hamburg; ⁴Department of Clinical Pharmacology, Universitatsklinikum, University of Bonn, Germany
pp. 123-123(1)

Possible influence of extremely low frequency (ELF) electromagnetic radiation fields (EMF) on atherosclerosis - B.R. Henderson¹, G. Pfister¹, M. Kind¹, G. Boeck², G. Wick^1,2. ¹Institute for Biomedical Aging Research, Austrian Academy of Sciences; ²Department of Pathophysiology, University of Innsbruck, Austria
pp. 123-123(1)

Fatty acid-induced endothelial cell activation - B. Hennig, V. Saraswathi, M. Toborek. Cell Nutrition Group, University of Kentucky, Lexington, KY, USA
pp. 123-123(1)

Role of hyperhomocysteinemia in atherothrombotic stroke - N. Degirmenci¹, B. Ince¹, G. Hergenc². ¹Istanbul University, Capa Medical Faculty, Department of Neurology; ²Yildiz TU Department of Biology, Bogazici University, Department of Biology and Genetics, Istanbul, Turkey
pp. 123-123(1)

Study in population with a high prevalence of metabolic syndrome and factor analysis of components of the syndrome - A. Onat, S. Toprak, V. Sansoy, G. Hergenc. Turkish Society of Cardiology, Istanbul, Turkey
pp. 123-124(2)

High-throughput fluorescence screening of antioxidant capacity in human serum. Effects of dietary flavonoids on lipid and protein oxidation - A. Hermetter, B. Mayer. Technische Universitat Graz, Austria
pp. 124-124(1)

Screening ASP9-ASN polymorphism in exon 2 of lipoproteinlipase GEN in familiar combined hyperlipidemia (FCHL) - A. Hernandez-Mijares¹, M. Casado², M.L. Martinez-Triguero¹, A. Lopez-Ruiz¹, E. Sola¹, S. Garzon¹, A. Lopez-Gutierrez¹, C. Morillas¹. ¹Hospital Universitario Doctor Peset; ²Instituto de Biomedicina, Valencia, Spain
pp. 124-124(1)

Principles of homocysteine metabolism in health and disease - W. Herrmann. Central Laboratory, University Hospital of The Saarland, Homburg, Germany
pp. 124-124(1)

How a receptor for oxidized low density lipoproteins works in humans - insights from human CD36 deficiency - K.-I. Hirano, T. Kuwasako, Y. Nakagawa-Toyama, T. Sugimoto, M. Ishigami, N. Sakai, S. Yamashita, Y. Matsuzawa. Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Japan
pp. 124-124(1)

Influence of LDL receptor gene polymorphisms on serum lipid levels and response to atorvastatin in subjects with familial and non familial hypercholesterolemia - L.A. Salazar^1,5, M.H. Hirata¹, S.A. Cavalli¹, E.R. Nakandakare², N.A. Forti³, J. Diament³, S. Giannini³, M.C. Bertolami⁴, R.D.C. Hirata¹. ¹Faculty of Pharmaceutical Sciences, ²Endocrinology Service, ³Heart Institute (InCor), Medical School, University of Sao Paulo; ⁴Dante Pazzanese Cardiology Institute, Sao Paulo, SP, Brazil; ⁵Faculty of Medicine, University of La Frontera, Temuco, Chile
pp. 125-125(1)

Relations between carotid plaques, intima media thickness and morbidity in elderly men with longstanding hypercholesterolemia - E.M. Hjerkinn, L. Bergengen, I. Seljeflot, I. Hjermann, H. Arnesen. Ulleval Univeristy Hospital, Oslo, Norway
pp. 125-125(1)

Inflammatory endothelial cell markers and morbidity in elderly high risk men - E.M. Hjerkinn, I. Seljeflot, I. Hjermann, H. Arnesen. Ulleval University Hospital, Oslo, Norway
pp. 125-125(1)

B-mode detection of subclinical atherosclerosis - H.N. Hodis, W.J. Mack. Univeristy of Southern California School of Medicine, Los Angeles, CA, USA
pp. 125-125(1)

Non-invasive detection and characterization of coronary atherosclerotic plaque - U. Hoffmann, R. Chan, T. Brady. Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
pp. 126-126(1)

Subjects with the AA genotype of the A278-C polymorphism in the cholesterol 7-hydroxylase gene display a lower response to a dietary challenge with cholesterol or cafestol than CC homozygotes - M.K. Hofman^1,2, R.M. Weggemans², P.L. Zock², E.G. Schouten², M.B. Katan², H.M.G. Princen¹. ¹Gaubius Laboratory TNO-PG, Leiden; ²Wageningen University, The Netherlands
pp. 126-126(1)

Iron and ferritin levels and iron/ferritin ratio in coronary disease patients - C. Holgado, T. Holgado, J. De La Vega, A. Aznar, F. Fabiani, M.A. Rico. H.U. Virgen Macarena, Sevilla, Spain
pp. 126-126(1)

Obese children have high ultrasensitive C-reactive protein (HSCRP) levels - G. Holzer¹, M. Exner¹, H. Rumpold¹, K. Widhalm², B. Jilma³, O. Wagner¹, S. Kapiotis¹. ¹Department of Medical and Chemical Laboratory Diagnostics, ²Department of Pediatrics, ³Department of Clinical Pharmacology, General Hospital, University of Vienna, Austria
pp. 126-126(1)

Hyperhomocystinaemia may account for the excess CHD risk in UK Indian Asians compared with European whites - J. Hooper, M. Kemp, J. Donovan, J. Chambers. Clinical Biochemistry, Royal Brompton Hospital, London, UK
pp. 126-126(1)

Tangier disease: A case report - G.K. Hovingh¹, A. Van Tol², A.H.M. Smelt³, M.R. Hayden⁴, J.J.P. Kastelein¹, J.A. Kuivenhoven¹. ¹Department of Vascular Medicine, Academic Medical Center Amsterdam; ²Department of Biochemistry, Erasmus University, Rotterdam; ³Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands; ⁴Center for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada
pp. 127-127(1)

Incidence of ABCAI gene defect in hypoalphalipoproteinemic cohort in the Netherlands - G.K. Hovingh¹, M. Van Wijland¹, M.R.H. Hayden², J.J.P. Kastelein¹, A.K. Groen¹. ¹Academic Medical Center, Amsterdam, The Netherlands; ²University of British Columbia, Vancouver, Canada
pp. 127-127(1)

Metabolism of beta2-glycoprotein I in mice - impact of the asialoglycoprotein receptor - A. Hrzenjak¹, S. Frank¹, Y. Zhou², G.M. Kostner¹. ¹Institute of Medical Biochemistry and Medical Molecular Biology, Karl-Franzens-University, Graz, Austria; ²Department of Biochemistry, Hadassah Medical School, Jerusalem, Israel
pp. 127-127(1)

Apolipoprotein A5 polymorphisms and plasma levels of triglycerides - J.A. Hubacek, V. Adamkova, V. Lanska, R. Poledne. IKEM, Prague, Czech Republic
pp. 127-127(1)

Fibrinolytic parameters as prothrombotic risk factors in atherosclerosis: t-PA and PAI-1 - K. Huber. Department of Cardiology, University of Vienna, Austria
pp. 127-128(2)

Gene-environment interaction in coronary artery disease (CAD) - S.E. Humphries. Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Royal Free and University College Medical School, London, UK
pp. 128-128(1)

Potential contribution of phospholipase A2 activity in atherosclerosis - E. Hurt-Camejo¹, B. Rosengren¹, H. Peilot², C. Hallberg¹, G. Camejo¹. ¹AstraZeneca, R&D, Molndal; ²Wallenberg Laboratory, Sahlgrenska Akademin, Gothenburg, Sweden
pp. 128-128(1)

Circadian variation of silent myocardial ischemia in hypertensives and its electrocardiographic features in a 24 hour holter monitoring - C.A.T. Ibanez, R.E. Ramboyong, E.S. Caguioa, D.R. Flores Jr., R.V. Anastacio. Section of Cardiology, Santo Tomas University Hospital, Manila, Philippines
pp. 128-128(1)

Implications of SNPs and ethnic diversities in different genes related to thrombotic factors for atherosclerosis - A. Ichinose. Yamagata University School of Medicine, Department of Molecular Pathobiology, Yamagata, Japan
pp. 128-128(1)

Antioxidant enzymes activities in patients with familial LCAT deficiency - B. Idzior Walus¹, T. Wesolowska², M. Walus¹, J. Sieradzki¹. ¹Collegium Medicum, Jagiellonian University, Krakow; ²Pomeranian Medical Academy, Poland
pp. 128-129(2)

A polymorphism in the upstream region of the PKC beta gene is associated with macrovascular diseases in Japanese patients with type 2 diabetes - Y. Ikeda, T. Suehiro, F. Osaki, S. Tsuzura, Y. Kumon, K. Hashimoto. Kochi Medical School, Nankoku, Kochi, Japan
pp. 129-129(1)

Detection of heterozygous lipoprotein lipase (LPL) gene mutations by electrochemical hybridization assay with ferrocenylnaphthalene diimide - Y. Ikeda¹, A. Takagi¹, K. Yamashita², S. Takenaka², T. Miyahara³, M. Takagi². ¹National Cardiovascular Center Research Institute, Suita, Osaka; ²Kyushu University, Fukuoka; ³TUM GENE INC, Chiba, Japan
pp. 129-129(1)

Effect of lycopene at hemostasis system of women with diabetes mellitus - M.V. Ilina, A.M. Olferiev, N.V. Berzak, A.H. Stecenco, V.M. Shamarin, A.B. Kapitanov. National Research Center for Preventive Medicine, Moscow, Russia
pp. 129-129(1)

Serum paraoxonase activity changes in patients after coronary artery bypass grafting - L. Illyes¹, I. Seres², P. Fulop², G. Paragh². ¹St. Ferenc Hospital, Miskolc; ²First Department of Medicine, Medical and Health Science Center, University of Debrecen, Hungary
pp. 129-129(1)

Effect of colesevelam HCL, a novel bile acid sequestrant, on LDL particle size in patients with moderate hypercholesterolemia - J. Isaacsohn¹, P. Jones². ¹Metabolic and Atherosclerosis Research Center, Cincinnati, OH; ²Baylor Lipid Clinic, Houston, TX, USA
pp. 129-130(2)

Different risk factors for peripheral vascular calcification between diabetic and non-diabetic hemodialysis patients - importance of glycemic control - E. Ishimura¹, S. Okuno², S. Kitatani², M. Kim², T. Shoji¹, M. Inaba¹, Y. Nishizawa¹. ¹Osaka City University Graduate School of Medicine; ²Shirasagi Hospital, Japan
pp. 130-130(1)

Achievement of the joint European societies LDL-cholesterol goal by hypercholesterolaemic patients receiving rosuvastatin or atorvastatin - H. Istad¹, L. Ose², S. Stender³, H. Southworth⁴, J. Pears⁴. ¹Theresegate Legesenter, Oslo; ²Rikshospitalet, Oslo, Norway; ³University of Copenhagen, Copenhagen, Denmark; ⁴AstraZeneca, Macclesfield, Cheshire, UK
pp. 130-130(1)

The carotid intima-medial thickness as a marker of severe coronary artery disease - E. Izcovich, V. Daru, E. Salmon, S. Baratta, R. Iglesias, M. Gonzalez, A. Sosa Liprandi. Sanatorio Mitre, Buenos Aires, Argentina
pp. 130-130(1)

Acute effects of cholesterol and fibrinogen removal on myocardial vasoreactivity in heart transplant patients - B.R. Jaeger, F. Bengel, K. Odaka, P. Ueberfuhr, E. Kreuzer, M. Schwaiger, B. Reichart, D. Seidel. Ludwig-Maximilians-Universitaet Munchen, Germany
pp. 130-131(2)

Postoperative lowering of plasma fibrinogen and LDL by apheresis for the prevention of early graft closure after coronary bypass grafting - B.R. Jaeger, M. Oberhoffer, E. Kreuzer, F. Blessing, J. Schirmer, T. Kauke, B. Reichart, D. Seidel. Ludwig-Maximilians-Universitaet Munchen, Germany
pp. 131-131(1)

Drastic cholesterol and fibrinogen reduction improves long-term survival in heart transplant recipients with transplant coronary artery disease - B.R. Jaeger, M. Oberhoffer, E. Kreuzer, J. Schirmer, P. Ueberfuhr, B. Reichart, D. Seidel Ludwig-Maximilians-Universitaet Munchen, Germany
pp. 131-131(1)

Sight of a peak in the treatment of severe hyperlipoproteinemia(a) [Lp(a)] - B.R. Jaeger, D. Seidel. Ludwig-Maximilians-Universitaet Munchen, Germany
pp. 131-131(1)

H.E.L.P. apheresis for the treatment of acute myocardial infarction - B.R. Jaeger, P. Uberfuhr, A. Knez, M. Oberhoffer, A. Leber, B. Reichart, D. Seidel. Ludwig-Maximilians-Universitaet Munchen, Germany
pp. 131-131(1)

PPAR alpha activators reduce triglyceride levels through activation of apolipoprotein as - H. Jakel¹, P. Gervois¹, N. Vu-Dac¹, M. Nowak¹, L.A. Pennacchio², E.M. Rubin², J. Fruchart¹, J.-C. Fruchart¹. ¹Departement d'Atherosclerose, U545 INSERM, Institut Pasteur de Lille and Faculte de Pharmacie de Lille, France; ²Genome Sciences Department, Berkeley, CA, USA
pp. 131-132(2)

B-mode ultrasound measurements of achilles tendons in patients with familial hypercholesterolemia and controls - L. Jakulj¹, M. Basart¹, M. Trip¹, D. Marais², J. Kastelein¹, E. De Groot¹. ¹Academic Medical Centre, Amsterdam, The Netherlands; ²University of Cape Town, Health Science Faculty, Cape Town, South Africa
pp. 132-132(1)

Efficacy of 'EDTA' on coronary artery disease - F. Jalali, S. Tabiban. Babol University of Medical Sciences, Babol, Iran
pp. 132-132(1)

Do fingerprints predict acute myocardial infarction? - F. Jalali, H Tilaki. Babol University of Medical Sciences, Babol, Iran
pp. 132-132(1)

Prevalence of hypertension and obesity in Iran - F. Jalali. Babol University of Medical Sciences, Babol, Iran
pp. 132-132(1)

Cardiovascular risk factors in familial hypercholesterolemia - A.C.M. Jansen, J.J.P. Kastelein. Academic Medical Center, Amsterdam, the Netherlands
pp. 132-133(2)

Impact of polymorphisms of the IL-6 and TNF- genes on cardiovascular risk markers in a large population - A. Jellema^1,2, E.J.M. Feskens², R.P. Mensink¹, W.H.M. Saris¹, D. Kromhout². ¹University of Maastricht; ²National Institute of Public Health and the Environment, Bilthoven, the Netherlands
pp. 133-133(1)

Cardiovascular risk markers in an overweight and normal weight population with oversampling of carriers of the IRS-1 972ARG variant - A. Jellema^1,2, E.J.M. Feskens², R.P. Mensink¹, W.H.M. Saris¹, D. Kromhout². ¹University of Maastricht; ²National institute of public health and the environment, Bilthoven, the Netherlands
pp. 133-133(1)

Effects of the thyroid receptor-beta agonist, GC-1, on cholesterol and triglyceride metabolism in intact male mice - L. Johansson¹, B. Angelin¹, M. Rudling¹, T. Scanlan², J. Baxter², P. Parini¹. ¹Metabolism Unit, Center for Metabolism and Endocrinology, Department of Medicine and Molecular Nutrition Unit, Center for Nutrition and Toxicology, Karolinska Institute at Huddinge Hospital, Stockholm, Sweden; ²Metabolic Research Unit and Department of Pharmaceutical Chemistry and Molecular and Cellular Pharmacology, University of California, San Francisco, CA, USA
pp. 133-133(1)

Formation and incorporation of genistein derivatives in human plasma lipoproteins - M.H. Kaamanen¹, H. Adlercreutz^2,3, M. Jauhiainen⁴, M.J. Tikkanen¹. ¹Department of Medicine, ²Division of Clinical Chemistry, University of Helsinki; ³Folkhalsan Research Center, Institute for Preventive Medicine Nutrition and Cancer; ⁴Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland
pp. 133-133(1)

The effect of 7-year infancy-onset dietary intervention on serum LDL and HDL cholesterol subclasses in healthy children: The prospective, randomised strip study - T. Kaotosaari, T. Ronnemaa, S. Talvia, J. Viikari, O. Simell. University of Turku, Finland
pp. 133-134(2)

Extralipid effects of fenofibrate in patients with combined hyperlipidemia - Z. Kalina, B. Okopien, L. Cwalina, D. Belowski, A. Madej, M. Zielinski, Z.S. Herman. Department of Clinical Pharmacology and Department of Internal Diseases, Silesian Medical University, Katowice, Poland
pp. 134-134(1)

Effectivity of Simvastatin on lipid changes and their mutual correlations - A. Kalvelis, G. Bahs. Medical Academy of Latvia, Riga, Latvia
pp. 134-134(1)

Influence of an antioxidant probucol in a dosage of 250 mg/day on the frequency of restenosis after percutaneous transluminal coronary angioplasty (PTCA) - A. Kaminniy, V. Kukharchuk, V. Lankin, A. Samko. Cardiology Research Center, Moscow, Russia
pp. 134-134(1)

Plasma D-dimer level and risk of coronary artery disease - N. Domanic, B. Karadag. 1st University, Cerrahpasa Medical Faculty Istanbul, Turkey
pp. 134-134(1)

Low molecular weight Lp(a) increases the PAI-1 mRNA transcription in brain microvascular endothelial cells - I. Karadi¹, J. Skopal², L. Romics¹, Z. Nagy², ¹3rd Department of Internal Medicine, ²National Stroke Center, Semmelweis University, Budapest, Hungary
pp. 134-135(2)

Hypolipidemic effect of lacipil in hypertensives with heart failure - I.G. Alizade, N.T. Karaeva. Hospital of Ministry of Internal Affairs, Baku, Azerbaijan
pp. 135-135(1)

Pritor in the treatment of patients with hypertension and obesity - I.G. Alizade, N.T. Karaeva. Hospital of Ministry of Internal Affairs, Baku, Azerbaijan
pp. 135-135(1)

Endothelial dysfunction in members of families with familial combined hyperlipidemia - D. Karasek, H. Vaverkova, M. Hutyra, M. Halenka, D. Novotny, L. Slavik, M. Budikova. University Hospital, Olomouc, Czech Republic
pp. 135-135(1)

Inactive and active forms of plasma phospholipid transfer protein (PLTP) are associated with apolipoprotein/lipid complexes - M. Karkkainen¹, T. Oka², V.M. Olkkonen¹, J. Metso¹, O. Eriksson³, H. Hattori², M. Jauhiainen¹, C. Ehnholm¹. ¹Department of Molecular Medicine, National Public Health Institute, Biomedicum, Helsinki, Finland; ²Research Division, Research and Development Center, BML Inc., Matoba, Kawagoe, Saitama, Japan; ³Institute of Biomedicine, University of Helsinki, Biomedicum, Helsinki, Finland
pp. 135-135(1)

Vitamin C reduces aortic lesion formation and improves endothelium-dependent relaxations in atherosclerotic mice - L.V. d'Uscio, L. Smith, Z.S. Katusic. Mayo Clinic, Rochester, MN, USA
pp. 136-136(1)

Ribozyme-mediated gene targeting of transcriptional coactivators, creb binding protein (CBP) and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-activated receptor-gamma - T. Kawada^1,2, N. Takahashi^1,2, T. Yamamoto¹, T. Goto¹, A. Taimatsu¹, N. Aoki³, H. Kawasaki⁴, K. Taira⁵, K.K. Yokoyama⁶, Y. Kamei⁷, T. Fushiki¹. ¹Division of Food Science and Biotechnology, Kyoto University; ²Project for Obesity and Lipid Metabolism Regulation, BRAIN, Tokyo; ³Department of Applied Molecular Bioscience, Nagoya University; ⁴Department of Chemical and Biotechnology, The University of Tokyo; ⁵Gene Discovery Research, AIST, Tsukuba; ⁶Tsukuba Life Science Center, RIKEN, Tsukuba; ⁷PREST, Japan Science and Technology Corporation, Tokyo, Japan
pp. 136-136(1)

Neutrophil superoxide anion generation during atorvastatin and flivastatin treatment used in coronary heart disease primary prevention - J. Kowalski, J. Kedziora, J. Blaszczyk, L. Pawlicki, J. Grycewicz, E. Rapacka. Military Medical University, Lodz, Poland
pp. 136-136(1)

The adipocyte as an endocrine and a no producing organ - U. Keller¹, B. Muller¹, P. Linscheid². ¹Division of Endocrinology, ²Department of Research, University Hospital, Basel, Switzerland
pp. 136-136(1)

Quality of life, anxiety and concerns of children with familial hypercholesterolemia and their parents - S. De Jongh¹, M.C. Kerckhoffs¹, M.A. Grootenhuis², B.F. Last², H.D. Bakker³. ¹Department of Vascular medicine, ²Paediatric Psychosocial Department, Emma Children's Hospital, Academic Medical Center; ³Emma Children's Hospital, Academic medical Center, Amsterdam, The Netherlands
pp. 136-137(2)

Effect of combined hypotensive and hypolipidemic therapy on CHD metabolic risk factors in NIDDM patients - L. Khadipash, M. Mamedov, O. Kosmatova, N. Perova. National Research Center for Preventive Medicine, Moscow, Russia
pp. 137-137(1)

Toll-like receptor 4 polymorphisms and atherogenesis in humans - S. Kiechl¹, E. Lorenz², M. Reindl², C.J. Wiedermann³, J. Willeit¹, D. Schwartz⁴. ¹Department of Neurology, University Clinic Innsbruck, Austria; ²Wake Forest University Medical School, NC, USA; ³Department of Internal Medicine, University Clinic Innsbruck, Austria; ⁴Department of Medicine and Genetics, Duke University Medical Center and Veterans Affairs Medical Center, Durham, NC, USA
pp. 137-137(1)

Apolipoprotein B-100/apolipoprotein A-I ratio is the most useful indicator for coronary artery disease in Koreans - H.-K. Kim, K.-W. Park, E.-K. Choi, D.-H. Kim, S. Oh, I.-H. Chae, H.-S. Kim, C.-H. Kim, D.-W. Sohn, B.-H. Oh, M.-M. Lee, Y.-B. Park, Y.-S. Choi. Heart Research Institute, Department of Internal Medicine, Cardiovascular Research Laboratory, Seoul National University Hospital, Seoul, Korea
pp. 137-137(1)

Arterial stiffness in patients with diabetic nephropathy. Comparison among different arterial segments - E. Kimoto, T. Shoji, K. Shinohara, M. Komatsu, A. Tanaka, S. Fujiwara, H. Koyama, M. Emoto, Y. Nishizawa. Osaka City University Graduate School of Medicine, Osaka, Japan
pp. 137-137(1)

Effects of cupressus sempervirens cone exctract on lipid profile in wistar rats - S. Karkabounas¹, D. Kiortsis¹, J. Zelovitis¹, P. Skafida¹, C. Demetzos⁴, M. Malamas², M. Elisaf³, A. Evangelou¹. ¹Laboratory of Physiology, ²Laboratory of Pharmacology, ³Department of Internal Medicine, University of Ioannina; ⁴Department of Pharmacognosy, School of Pharmacy, Univesrity of Athens, Greece
pp. 137-138(2)

Plaque stabilization effects of the atorvastatine - N. Kipshidze, N. Kakauridze. Research Institute of Clinical and Experimental Therapy, Tbilisi, Georgia
pp. 138-138(1)

Oxidized LDL receptors and atherosclerosis - T. Kita. Kyoto University, Department of Geriatric Medicine, Kyoto, Japan
pp. 138-138(1)

Arterial wall stiffness is associated with peripheral circulations in patients with type 2 diabetes - A. Kizu, H. Koyama, S. Tanaka, T. Maeno, M. Komatsu, M. Emoto, H. Yokoyama, T. Shoji, M. Inaba, Y. Nishizawa. Osaka City University Graduate School of Medicine, Osaka, Japan
pp. 138-138(1)

Suppression of inflammation markers and cellular immune function in obese (OB/OB) mice - Z. Berke, M. Kjerrulf, N. Oakes, E. Hurt-Camejo. AstraZeneca R&D, MoIndal, Sweden
pp. 138-138(1)

Cholesteryl ester transfer protein (CETP) concentration influences progression of atherosclerosis and response to pravastatin treatment; the regress study - A.H.E.M. Klerkx¹, G.J. De Grooth¹, A.H. Zeinderman^1,2, J.W. Jukema², J.A. Kuivenhoven¹, J.J.P. Kastelein¹. ¹Academic Medical Center, University of Amsterdam; ²Leiden University Medical Center, The Netherlands
pp. 138-139(2)

Haplotype analysis of gene variations closely linked to the Taqib polymorphism in the cholesteryl ester transfer protein (CETP) gene reveals independent associations of the -629 and a novel promoter polymorphism with CETP and HDL-C levels - A.H.E.M. Klerkx¹, M.W.T. Tanck^1,2, J.J.P. Kastelein¹, J.W. Jukema², A.H. Zwinderman^1,2, J.A. Kuivenhoven¹. ¹Academic Medical Center, University of Amsterdam; ²Leiden University Medical Center, The Netherlands
pp. 139-139(1)

Immunological and classical risk factors for atherosclerosis in young Austrian males - M. Knoflach¹, H. Perschinka¹, M. Kind¹, M. Said², R. Sief³, M. Giesinger², B. Mayrl¹, H. Gaston⁴, R. Van Der Zee⁵, S. Kiechl⁴, J. Willeit⁴, G. Wick¹. ¹Institute for Biomedical Aging Research, Austrian Academy of Sciences; ²Military Hospital; ³Military Recruiting Bureau, Innsbruck, Austria; ⁴Department of Medicine, University of Cambridge, UK; ⁵Department of Physiology, Cardiovascular Research Institute, Maastricht University, The Netherlands
pp. 139-139(1)

Peroxynitrite and myocardial adenosine production-protective effect of melatonin - G. Kocic, R. Kocic, G. Bjelakovic, T. Jevtovic, R. Pavlovic, D. Pavlovic. Institute of Biochemistry, Institute of Chemistry and Clinic for Endocrinology, Medical Faculty, Nis, Yugoslavia
pp. 139-139(1)

Atorvastatin therapy of hyper-cholesterolemia in diabetics - more than one benefit - R. Kocic, D. Pavlovic, G. Kocic. Clinic for Endocrinology and Institute of Biochemistry Medical Faculty, Nis, Yugoslavia
pp. 139-140(2)

The influence of sodium monoketocholate on hypolipidemic effects of lovastatin in healthy and diabetic rats - S. Kojic-Damjanov¹, M. Djeric¹, M. Mikov². ¹Institute of Laboratory Medicine, Novi Sad Clinical Center; ²Institute of Pharmacology, Toxicology and Clinical Pharmacology, Novi Sad Medical School, Yugoslavia
pp. 140-140(1)

LDL-apheresis by immunoadsorption with 'LDL Lipopak' columns can lead stabilization and even regression of atherosclerotic plaques in coronary arteries - G.A. Konovalov¹, A.N. Chebyshev¹, V.V. Kukharchuk², I.Y. Adamova², O.I. Afanasieva², S.G. Kipor³, S.N. Pokrovsky². ¹The Medical Centre of Management Department of The President of The Russian Federation; ²Cardiology Research Centre; ³POCARD Ltd., Moscow, Russia
pp. 140-140(1)

Fourteen years experience of the statins application for the patients with primary hypercholesterolaemia - G.A. Konovalov, P.V. Zvezdkin, A.A. Vinnikova, T.S. Kurganskaya, N.K. Golubeva. Medical Centre of The Management Department of The President of The Russian Federation, Moscow, Russia
pp. 140-140(1)

Specific Lp(a)-apheresis with immunoadsorption - new tool for the treatment of severe CHD patients with elevated Lp(a) - S.N. Pokrovsky¹, O.I. Afanasieva¹, I.Y. Adamova¹, A.V. Sussekov¹, V.V. Kukharchuk¹, S.G. Kipor², G.A. Konovalov³. ¹Cardiology Research Centre; ²POCARD Ltd.; ³Medical Centre of Management Department of The President of The Russian Federation, Moscow, Russia
pp. 140-140(1)

The time course of coronary heart disease after revascularisation procedures - V. Konstantinov, V. Gloukhov. Institute for Experimental Medicine, St. Petersburg, Russia
pp. 140-141(2)

LDL-receptor gene mutations, blood lipid levels and clinical manifestations of atherosclerosis in patients with familial hypercholesterolemia and in their close relatives - V. Konstantinov¹, I. Liberman¹, A. Denisenko¹, V. Larionova², E. Schwartz³. ¹Institute for Experimental Medicine; ²Pediatric Medical Academy; ³Institute of Nuclear Physics, St. Petersburg, Russia
pp. 141-141(1)

Mildly oxidised LDL subspecies are distinct in their capacity to induce apoptosis in endothelial cells: Role of lipid hydroperoxides - A. Kontush¹, L. Chancharme¹, I. Escargueil-Blanc², R. Salvayre², A. Negre-Salvayre², M.J. Chapman¹. ¹INSERM Unite 551, Hopital de la Pitie, Paris; ²INSERM Unite 466, CHU Rangueil, Toulousse, France
pp. 141-141(1)

Platelet-monocyte cross talk and tissue factor expression in stable angina versus unstable angina/non-st-elevation myocardial infarction - C.W. Kopp, S. Steiner, D. Seidinger, N. Iordanova, G. Maurer, E. Minar, K. Huber. 2nd Department of Medicine, University of Vienna, Austria
pp. 141-141(1)

Prevention of LDL modification by trecresan - M.M. Korda. Ternopil State Medical Academy, Ternopil, Ukraine
pp. 141-141(1)

The functional state of the hemostasis system in traumatologic and orthopedic patients with atherosclerosis - G.V. Korshunov, D.M. Puchinyan, A.G. Korshunov, L.O. Khvichiya, I.V. Matasova, S.I. Yaroshevskaya, S.G. Shahmartova. The Scientific Research Institute of Traumatology and Orthopedics, Saratov, Russia
pp. 142-142(1)

Mapping of quantitative trait loci involved in atherosclerosis in the mouse - R. Korstanje, R. Li, G. Churchill, B. Paigen. The Jackson Laboratory, Bar Harbor, ME, USA
pp. 142-142(1)

Fetal therapy effect on the hemostasis correction - L. Koryakina, V. Marchenko, L. Zubareva, A. Runovich. Center of Reconstructive Sugery, Irkutsk, Russia
pp. 142-142(1)

Influence of irbesartan on plasma concentrations of adhesion molecules and chemokines in coronary heart disease with documented coronary atherosclerosis - I.V. Korzh, Kharkov Medical University, Kharkov, Ukraine
pp. 142-142(1)

The influence of lipid-lowering treatment on nitric oxide synthesis in endothelial cells - I.V. Korzh, Kharkov Medical University, Kharkov, Ukraine
pp. 142-142(1)

Role of pro-inflammatory cytokines and endothelial dysfunction in patients with angiografically proved coronary atherosclerosis - O.M. Korzh, Ukrainian National Academy of Pharmacy, Kharkov, Ukraine
pp. 142-143(2)

Relationship between endothelial nitric oxide synthesis and low-grade chronic inflammation - O.M. Korzh, Ukrainian National Academy of Pharmacy, Kharkov, Ukraine
pp. 143-143(1)

Treatment of obesity with traditional Chinese medicine - B. Kostner, Center for Holistic Medicine, Vienna, Austria
pp. 143-143(1)

Has Lp(a) any physiological function? - G.M. Kostner, Institute of Medical Biochemistry and Molecular Biology, University of Graz, Austria
pp. 143-143(1)

A novel extracorporeal plasma delipidation procedure for the treatment of atherosclerosis - K.M. Kostner¹, J.L. Smith², B.E. Cham³. ¹Lipidsciences, Greenslopes Private Hospital; ²University of Queensland; ³Curacel Institute of Medical Research, Queensland, Australia
pp. 143-143(1)

Experimental hyperlipidemia and the effect of NSAIDs - A. Kourounakis, P. Victoratos, N. Peroulis, N. Stefanou, M. Yiangou, L. Hadjipetrou, P.N. Kourounakis, Department of Medical Chemistry, School of Pharmacy, Aristotles University of Thessaloniki, Greece
pp. 144-144(1)

Analysis of the peroxisome-deficient PEX2 zellweger mouse: Alteration in cholesterol homeostasis - W.J. Kovacs¹, K. Tape¹, J.E. Shackelford¹, S.J. Fliesler², P.L. Faust³, S.K. Krisans¹. ¹San Diego State University, San Diego, CA; ²Saint Louis University, St. Louis, MO; ³Columbia University, New York, NY, USA
pp. 144-144(1)

Hyperinsulinemia and hyperglycemia downregulate lipoprotein lipase activity - J. Kovar, V. Fejfarova, T. Pelikanova, R. Poledne. Institute for Clinical and Experimental Medicine, Prague, Czech Republic
pp. 144-144(1)

Erythrocytes and plasma malonyl dialdehyde (MDA) concentration during atorvastatin and fluvastatin treatment used in coronary heart disease primary prevention - J. Kowalski, J. Blaszczyki, L. Pawlicki, J. Grycewicz, P. Kaczmarek, E. Rapacka. Military Medical University, Lodz, Poland
pp. 144-144(1)

Effectiveness of action on prevention in the Southern Poland epidemiologic survey. Distribution of blood pressure in relation to age and gender - K. Kozakiewicz, M. Sosnowski, T. Pawlowski, K. Zaorski, P. Garbocz, M. Tendera. Silesian School of Medicine, Katowice, Poland
pp. 144-145(2)

Ferritin, oxidative stress and coronary heart disease - P. Kraml¹, J. Potockova¹, H. Koprivova³, S. Stipek², J. Crkovska² T. Zima², M. Andel¹. ¹2nd Department of Internal Medicine, Third Faculty of Medicine, ²1st Institute of Medical Chemistry and Biochemistry, First Faculty of Medicine, ³Department of Biochemistry, Third Faculty of Medicine, Charles University, Prague, Czech Republic
pp. 145-145(1)

Alternative pathway of free fatty acid uptake from phospholipids and upregulation of de novo fatty acid synthesis in lipoprotein lipase-deficient murine adipose tissue - D. Kratky^1,2, E.M. Wagner¹, R. Zimmermann¹, J.G. Strauss¹, G. Haemmerle¹, E. Steyrer², R. Zechner¹. ¹Institute of Molecular Biology, Biochemistry and Microbiology, ²Institute of Medical Biochemistry and Medical Molecular Biology, University of Graz, Austria
pp. 145-145(1)

Patient models of coronary heart disease - G. Krstacic, A. Krstacic, M. Jembrek-Gostovic. University Clinic 'Vuk Vrhovac', Zagreb, Croatia
pp. 145-145(1)

Plasma total homocysteine as a risk factor for coronary artery disease - M. Krstevska, S. Dzhekova-Stojkova, G. Bosilkova. Department of Biochemistry, Medical Faculty, Skopje, Republic of Macedonia
pp. 145-145(1)

Serum TNF- and its soluble receptors I and II in the postmenopausal women (PMW) with a known risk of atheromatosis - R. Dybkowski¹, J. Krzysiek¹, T. Milewicz¹, A. Janczak-Saif¹, G. Krzysiek², K. Sztefko³, M. Radecka¹, M. Kacprzak¹. ¹Endocrinology and Fertility Clinic, School of Medicine; ²Molecular Biology Institute, ³Department of Clinical Biochemistry, School of Medicine, Jagiellonian University, Cracow, Poland
pp. 145-146(2)

The change of composition as well as the concentration of serum Lp(a) can be a sign for end-stage renal failure - M. Kuboyama, M. Ageta, K. Nishihira, Y. Arimura, T. Shigenaga, T. Ishihara, J.-I. Ashitani, Y. Fujiura, N. Kashio, I. Ikushima. Nichinan Hospital, Miyazaki, Japan
pp. 146-146(1)

Heterozygosity for ABCAI gene mutations; effects on lipid metabolism - J.A. Kuivenhoven, G.K. Hovingh, A. Van Tol, A.H. Smelt, J.C. Fruchart, E. Brinton, J.D. Otvos, A.H. Zwinderman, M.R. Hayden, J.J.P. Kastelein
pp. 146-146(1)

Effect of blood lipoproteins on contractile function of vessels in rats - O.K. Kulchistky, S.N. Novikova, N.V. Sikalo. Institute of Gerontology, Kiev, Ukraine
pp. 146-146(1)

Increased P-selectin in smokers with CHD - W.C. Kullich¹, G. Klein^1,2. ¹Ludwig Boltzmann Institute for Rehabilitation of Internal Diseases; ²Special Hospital/Rehabilitation Centre for Cardiovascular and Rheumatic Diseases, Saalfelden, Austria
pp. 146-146(1)

Differential profiles of early versus later onset peripheral arterial occlusive disease - S.N. Barretto, I.J. Kullo. Mayo Clinic, Rochester, MN, USA
pp. 147-147(1)

Low cardiorespiratory fitness is associated with the metabolic syndrome in middle-aged male executives - I.J. Kullo, D.D. Hensrud, T.G. Allison. Mayo Clinic, Rochester, NM, USA
pp. 147-147(1)

Structure of correlations between cerebral blood flow values in various brain areas in ischemic stroke patients with atherosclerosis - V.V. Kuznetsov. Institute of Gerontology, Kiev, Ukraine
pp. 147-147(1)

Atherosclerotic lesions of major head arteries: Age peculiarities - S.M. Kuznetsova¹, V.A. Rogozhin², I.I. Glazovskaya². ¹Institute of Gerontology. ²The Diagnostic Center, Kiev, Ukraine
pp. 147-147(1)

Aggressive lipid-lowering with statins and skeletal muscle ubiquinone: A randomised, controlled trial - H. Paiva¹, J. Laakso², T. Lehtimaki³, R. Laaksonen^3,4. ¹Department of Medicine, University Hospital of Tampere; ²Department of Clinical Pharmacology, University of Helsinki; ³Laboratory of Atherosclerosis Genetics, University Hospital of Tampere, Finland; ⁴Department of Neurology, Erasme Hospital, ULB, Brussels, Belgium
pp. 147-148(2)

Construction of high-capacity viral vectors for overexpression of full-length low-density-lipoprotein receptor-related protein (LRP) - A. Laatsch, J. Heeren, U. Beisiegel, F. Schnieders. University Hospital Hamburg-Eppendorf, Institute of Medical Biochemistry and Molecular Biology, Department of Molecular Cell Biology, Hamburg, Germany
pp. 148-148(1)

Primary and secondary prevention in hyperlipidaemic patients. Their compliance with directions and treatment given, according to the records of our clinics of hyperlipidaemias - D.K. Theodoridi, A.D. Labrou, A.G. Savvopoulou, L.F. Borghi, O.E. Koutsogiannis, A.N. Zagoutis, S.K. Terzi, A.E. Panagiotidou, A.K. Gotsis. Cardiology Department, General Hospital of Komotini, Greece
pp. 148-148(1)

Apoprotein(a) phenotypes and lipoprotein(a) concentration in patients with diabetes mellitus - D.D. Labudovic, B.B. Todorova, K.N. Toseska, S.B. Alabkovska. Department of ME Biochemistry, Medical Faculty, Skopje, Macedonia
pp. 148-148(1)

Intensification of LDL peroxidation during therapy by HMG-CoA reductase inhibitors - V. Lankin, A.K. Tikhaze, V.V. Kukharchuk. Cardiology Research Complex, Moscow, Russia
pp. 148-148(1)

Activation of thrombin and fibronolytic systems after thrombolysis in patients with acute myocardial infarction - G.S. Latsios¹, A.T. Anastasopoulou^1,2, N.V. Michalopoulos¹, A. Papanikitas¹, E. Dimoula¹, A.G. Georgoulas², A. Zaharof¹. ¹2nd Department of Medicine, ²2nd Department of Cardiology, Hellenic Red Cross Hospital, Athens, Greece
pp. 149-149(1)

Severity and extension of coronary artery disease in association to plasma fibrinogen levels - G.S. Latsios¹, A.T. Anastosopoulou^1,2, N.V. Michalopoulos¹, A. Papanikitas¹, G. Svoukas¹, A.G. Georgoulas², A. Zaharof¹. ¹2nd Department of Medicine, ²2nd Department of Cardiology, Hellenic Red Cross Hospital, Athens, Greece
pp. 149-149(1)

Absence of CMV DNA in endarterectomy specimens by the polymerase chain reaction (PCR) - G.S. Latsios, A. Saetta, N.V. Michalopoulos, G. Fanourakis, P.S. Davaris. Department of Pathology, Medical School, University of Athens, Greece
pp. 149-149(1)

Cardiovascular risk factors in type 2 diabetics: Role of hypertension and fibrinogen - P. Lazzari, A. Cappellini. Diabetes Center, Hospital of Cremona, Italy
pp. 149-149(1)

Regulation of human CETP gene promoter activity: Role of multiple binding sites for SP1 and SP3 transcription factors - W. Le Goff, M. Guerin, L. Petit, M.J. Chapman, J. Thillet. Inserm U551, Hopital de la Pitie, Paris, France
pp. 149-150(2)

Differential regulation of ABCA1 expression and cholesterol efflux during adipose differentiation - S. Le Lay, X. Le Liepvre, P. Ferre, I. Dugail. INSERM U465, Paris, France
pp. 150-150(1)

Contribution of Apo CIII reduction to the greater effect of micronized fenofibrate than atorvastatin of triglyceride levels and LDL size in dyslipidemic patients under treatment for 12 weeks - I. Lemieux^1,2, J.-P. Despres^1,2, Study Groups³, H. Salomon⁴. ¹Quebec Heart Institute, Ste-Foy, Quebec; ²Lipid Research Center, Ste-Foy, Quebec; ³, Canada; ⁴Laboratoires Fournier, Garches, France
pp. 150-150(1)

Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with the systemic inflammatory response syndrome (SIRS) - J.H.M. Levels, L.C.J.M. Lemaire, A.E. Van Den Ende, S.J.H. Van Deventer, J.J.B. Van Lanschot. Academic Medical Center, Amsterdam, The Netherlands
pp. 150-150(1)

The lipid transport proteins LBP and PLTP promote redistribution of endotoxin from HDL to other lipoproteins in vitro - J.H.M. Levels, A. Marquart, P.R. Abraham, A.E. Van Den Ende, H.O.F. Molhuizen, S.J.H. Van Deventer, J.C.M. Meijers. Academic Medical Center, Amsterdam, The Netherlands
pp. 150-150(1)

XIAP mediates cell-cycle arrest and activates NF-B: New survival pathways and their destruction by caspases during endothelial apoptosis - B. Levkau¹, K.J. Garton², N. Ferri², R.J. Nofer¹, H. Baba³, E.W. Raines², G. Breithardt⁴. ¹Institute for Arteriosclerosis Research at the University of Munster, Germany; ²Department of Pathology, University of Washington, Seattle, WA, USA; ³Department of Pathology, ⁴Department of Cardiology and Angiology, University of Munster, Germany
pp. 151-151(1)